{"gene":"AKAP12","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1998,"finding":"SSeCKS/AKAP12 associates with and controls elaboration of a cortical cytoskeletal matrix resistant to Triton X-100 extraction; ectopic SSeCKS expression in NIH3T3 cells caused cell flattening, loss of actin stress fibers and vinculin-associated adhesion plaques, and increased integrin-independent FAK tyrosine phosphorylation, establishing a direct role for SSeCKS in controlling actin-based cytoskeletal architecture.","method":"Tetracycline-regulated ectopic expression in NIH3T3 fibroblasts; immunofluorescence; cytochalasin/nocodazole inhibitor studies; biochemical fractionation","journal":"Cell motility and the cytoskeleton","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean inducible expression system with multiple orthogonal readouts (morphology, biochemistry, pharmacological perturbations), replicated in multiple papers","pmids":["9744295"],"is_preprint":false},{"year":1997,"finding":"SSeCKS re-expression in v-Src-transformed NIH3T3 cells suppressed oncogenic transformation parameters (soft agar growth, invasiveness, focus formation, low-serum growth) without inhibiting Src kinase activity or JNK activity, but induced ERK2 activity; SSeCKS restored vinculin-associated adhesion plaques, actin stress fibers, and filopodia, indicating tumor suppression via cytoskeletal and signaling control rather than direct Src kinase inhibition.","method":"Tetracycline-regulated SSeCKS expression in ts72v-src cell lines; soft agar assay; Matrigel invasion; in vivo/in vitro kinase assays; immunofluorescence","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays with inducible expression system, replicated across multiple subsequent studies","pmids":["9187136"],"is_preprint":false},{"year":2000,"finding":"SSeCKS induces G1 arrest by ERK2-dependent decrease in cyclin D1 expression and pRb phosphorylation; SSeCKS encodes two cyclin-binding (CY) motifs flanking PKC phosphorylation sites (Ser507/515) that bind cyclins D1 and E; K→S mutations in either CY motif ablate cyclin binding; PKC phosphorylation of SSeCKS at Ser507/515 releases cyclin D1 from cytoplasmic sequestration, allowing nuclear translocation; forced cyclin D1 re-expression fails to rescue SSeCKS-induced G1 arrest, demonstrating additional mechanisms.","method":"Tetracycline-regulated expression in NIH3T3; bacterially expressed SSeCKS-CY domain binding assays; site-directed mutagenesis; confocal microscopy; cell-permeable penetratin-linked peptides; pRb phosphorylation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding reconstitution with mutagenesis, live-cell imaging, and multiple orthogonal functional assays in one study","pmids":["10982843"],"is_preprint":false},{"year":2002,"finding":"SSeCKS encodes four calmodulin (CaM) binding sites conforming to the 1-5-10 motif; CaM binding is antagonized by PKC pre-phosphorylation of SSeCKS; two major cyclin-binding (CY) sites overlap the major PKC phosphorylation site (Ser507/515), and cyclin D binding is attenuated by PKC pre-phosphorylation, demonstrating phosphorylation-dependent modulation of SSeCKS scaffolding activity.","method":"In vitro binding assays with bacterially expressed SSeCKS fragments; PKC phosphorylation prior to binding; mapping by deletion analysis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with phosphorylation-dependent functional mapping, single lab","pmids":["11820772"],"is_preprint":false},{"year":2001,"finding":"SSeCKS/AKAP12 directly binds the cytoplasmic domain of beta1,4-galactosyltransferase I (GalT); identified by yeast two-hybrid screen and confirmed by reciprocal co-immunoprecipitation of both endogenous and transfected proteins; SSeCKS domains localized to Golgi (2.52) and filopodia (1.12) recapitulate GalT distribution; SSeCKS-GalT interaction restores normal adhesive phenotype disrupted by a dominant-negative GalT construct.","method":"Yeast two-hybrid screen; reciprocal co-immunoprecipitation; GFP-fusion localization; functional adhesion rescue assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with functional validation, single lab, multiple orthogonal methods","pmids":["11493668"],"is_preprint":false},{"year":2003,"finding":"Gravin/AKAP12 (AKAP250) dynamically associates with the beta2-adrenergic receptor (β2AR); the AKAP domain of gravin is essential for receptor binding (deletion abolishes binding); agonist stimulation induces gravin phosphorylation at two canonical PKA sites within its AKAP domain; PKA phosphorylation of these sites is required for scaffold-receptor association and for receptor resensitization; the AKAP-anchored PKA provides the catalytic activity responsible for phosphorylating the scaffold.","method":"Mutagenesis; metabolic labeling; biochemical co-immunoprecipitation; PKA inhibitor studies; receptor resensitization assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis combined with biochemical and functional assays; mechanism replicated in subsequent studies","pmids":["14657015"],"is_preprint":false},{"year":2003,"finding":"SSeCKS in astrocytes decreases VEGF expression through AP-1 reduction and stimulates angiopoietin-1 expression; conditioned media from SSeCKS-overexpressing astrocytes blocks angiogenesis in vivo and in vitro, increases tight junction proteins in endothelial cells, and decreases sucrose permeability, establishing SSeCKS as a regulator of BBB differentiation.","method":"SSeCKS overexpression in astrocytes; conditioned media transfer to endothelial cells; in vivo and in vitro angiogenesis assays; [3H]sucrose permeability assay; immunofluorescence; in vivo BBB maturation immunostaining","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo assays, widely replicated across subsequent papers","pmids":["12808449"],"is_preprint":false},{"year":2004,"finding":"AKAP12 encodes three isoforms (alpha, beta, gamma) from three independent promoters with distinct tissue expression profiles; the alpha isoform contains an N-terminal myristoylation motif shown by deletion mapping and GFP chimeras to be necessary and sufficient for targeting AKAP12alpha to the endoplasmic reticulum, a novel AKAP12 subcellular compartment.","method":"Comparative genomics; reporter assays; GFP chimera subcellular localization; myristoylation site mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization by live-cell imaging with mutagenesis validation, single lab","pmids":["15496411"],"is_preprint":false},{"year":2005,"finding":"AKAP12 contains five nuclear localization signals (NLS) in its central region (including a novel X2-NLS class) that confer nuclear targeting potential; this is suppressed by a negatively charged C-terminus mediating nuclear exclusion; three basic residue-rich regions in the N-terminal domain (similar to MARCKS) control AKAP12 localization to ganglioside-rich regions at the cell periphery, establishing a hierarchy of targeting domains.","method":"Cross-species sequence analysis; deletion mapping; GFP chimera live-cell imaging; subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GFP chimera localization with deletion mapping, single lab, no functional consequence directly demonstrated","pmids":["15923193"],"is_preprint":false},{"year":2006,"finding":"SSeCKS re-expression suppresses podosome formation via inhibition of RhoA and Cdc42 activity (>5-fold reduction); activated RhoA and Cdc42 rescue podosome formation in SSeCKS-expressing v-Src cells; SSeCKS does not affect Tks5/Fish tyrosine phosphorylation or total cellular tyrosine phosphorylation, placing SSeCKS downstream of Src kinase activity but upstream of RhoA/Cdc42-mediated cytoskeletal remodeling.","method":"Tetracycline-regulated SSeCKS expression; RhoA/Cdc42 activity assays; constitutively active GTPase rescue; Matrigel invasion; immunofluorescence","journal":"Molecular cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistasis by constitutively active GTPase rescue combined with activity assays, single lab with multiple orthogonal methods","pmids":["16547152"],"is_preprint":false},{"year":2006,"finding":"SSeCKS metastasis-suppressor activity correlates with suppression of VEGF expression in prostate cancer cells and tumor stroma; forced re-expression of VEGF165 or VEGF121 is sufficient to partially reverse SSeCKS metastasis suppression in both experimental and spontaneous lung metastasis models; SSeCKS also upregulates antiangiogenic genes (vasostatin, collagen 18a1) and downregulates proangiogenic genes (osteopontin, HIF-1alpha, angiopoietin).","method":"Tetracycline-regulated SSeCKS expression; spontaneous and experimental in vivo metastasis models; VEGF isoform forced re-expression rescue; gene expression analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo rescue experiments with defined molecular perturbations, replicated across multiple model systems","pmids":["16740695"],"is_preprint":false},{"year":2007,"finding":"AKAP12 downregulates HIF-1alpha protein by enhancing its interaction with pVHL (von Hippel-Lindau protein) and PHD2 (prolyl hydroxylase 2), leading to decreased VEGF and increased angiopoietin-1 in astrocytes; conditioned media from AKAP12-overexpressing astrocytes induces tight junction protein expression in human retinal microvascular endothelial cells, promoting blood-retinal barrier formation.","method":"AKAP12 overexpression in astrocytes; co-immunoprecipitation of HIF-1alpha with pVHL and PHD2; conditioned media transfer; tight junction protein western blot; in vivo immunostaining of human retinoblastoma samples","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP of HIF-1alpha complex combined with functional conditioned media assays, single lab, multiple methods","pmids":["17442832"],"is_preprint":false},{"year":2007,"finding":"v-Src downregulates SSeCKS alpha promoter via recruitment of HDAC1 to a USF1-Sp1/Sp3 complex at E- and GC-box elements (-106 to -49); v-Src increases Sp1/Sp3 binding to the GC-box without altering protein abundance; Src-induced tyrosine phosphorylation of TFII-I increases its binding to the SSeCKS proximal promoter and is required for full transcriptional repression; trichostatin A (HDAC inhibitor) but not 5-azacytidine restores SSeCKS transcript levels.","method":"Promoter deletion analysis; chromatin immunoprecipitation; HDAC1 siRNA knockdown; electrophoretic mobility shift assay; TFII-I mass spectrometry identification; TFII-I tyrosine phosphorylation mutant","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP, EMSA, siRNA, and mutagenesis in one study, single lab","pmids":["17626016","20568114"],"is_preprint":false},{"year":2008,"finding":"AKAP12 in astrocytes reduces phosphorylation of PKCzeta in retinal endothelial cells; PKCzeta knockdown decreases VEGF and increases thrombospondin-1 (TSP-1); inhibition of Rho kinase (Y27632) downstream of PKCzeta also decreases VEGF and increases TSP-1, establishing an AKAP12→PKCzeta→Rho kinase→VEGF/TSP-1 pathway mediating barriergenesis.","method":"Conditioned media from AKAP12-overexpressing astrocytes; siRNA-mediated PKCzeta knockdown; Rho kinase inhibitor Y27632; western blot for VEGF and TSP-1","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and siRNA pathway dissection, single lab, indirect readout via conditioned media","pmids":["18397319"],"is_preprint":false},{"year":2008,"finding":"Loss of SSeCKS/AKAP12 in knockout mice results in prostatic hyperplasia with focal dysplasia; SSeCKS-null prostate tissues exhibit significantly higher AKT(pS473) levels relative to wild-type, suggesting SSeCKS attenuates PI3K/AKT signaling in vivo.","method":"SSeCKS-null (knockout) mouse histology; western blot for pAKT(S473); E-cadherin and cytokeratin immunostaining","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse model with defined molecular readout, single lab","pmids":["18593908"],"is_preprint":false},{"year":2009,"finding":"SSeCKS suppresses serum-induced Raf/MEK/ERK pathway activation, leading to decreased MMP-2 expression and inhibition of chemotaxis and Matrigel invasion; constitutively active MEK1, MEK2, ERK1, or PKCalpha restores invasiveness and chemotaxis; SSeCKS attenuation of ERK activation requires its PKC-binding domain (aa 553-900), suggesting direct PKC scaffolding; jasplakinolide (actin stabilizer) nullifies SSeCKS inhibition of MEK/ERK activation but not podosome inhibition.","method":"Tetracycline-regulated SSeCKS expression; constitutively active kinase rescue; SSeCKS domain deletion analysis; chemotaxis assay; Matrigel invasion; MEK/ERK phosphorylation western blot; actin cytoskeleton perturbation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis by constitutively active rescue combined with domain deletion mapping and pharmacological perturbations, multiple orthogonal methods","pmids":["20018890"],"is_preprint":false},{"year":2010,"finding":"AKAP12-null MEF exhibit premature senescence marked by polyploidy and multinucleation; senescence is Rb-dependent; PKCα activation induces p16(Ink4a)/Rb through MEK-dependent downregulation of Id1; PKCδ downregulates Lats1/Warts kinase required for cytokinesis; Akap12 directly scaffolds and attenuates PKCα/δ, controlling Rb-mediated cell aging and cytokinesis.","method":"AKAP12-null (KO) mouse embryonic fibroblasts; PKC activity assays; p53/Rb pathway analysis; MEK inhibitor epistasis; senescence markers (SA-β-gal, p16, p21); polyploidy/multinucleation quantification","journal":"Cell cycle","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO MEF with defined pathway epistasis, multiple orthogonal readouts, mechanistic pathway mapping","pmids":["21099353"],"is_preprint":false},{"year":2011,"finding":"SSeCKS directly binds PKCα through two homologous motifs (EG(I/V)(T/S)XWXSFK(K/R)(M/L)VTP(K/R)K(K/R)X(K/R)XXXEXXXE(E/D); aa 592-620 and 741-769); SSeCKS binding to PKCα decreases kinase activity; SSeCKS scaffolding of PKC increases at confluence correlating with decreased PKCα activity; SSeCKS-null MEF show increased PKC activity and defective phorbol ester-induced actin cytoskeletal reorganization, rescued by full-length SSeCKS but not by PKC-binding domain-deleted SSeCKS.","method":"In vitro PKC binding assays with defined SSeCKS motifs; PKC kinase activity assays; SSeCKS-null MEF; domain deletion rescue; phorbol ester-induced cytoskeletal morphology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding reconstitution with motif mapping plus KO MEF rescue with deletion constructs, single lab","pmids":["21903576"],"is_preprint":false},{"year":2012,"finding":"SSeCKS sequesters cyclin D1 in the cytoplasm of quiescent glomerular parietal epithelial cells (PECs); PKC phosphorylation of SSeCKS disrupts binding, resulting in nuclear translocation of cyclin D1; co-immunoprecipitation demonstrates cyclin D1-SSeCKS complex in PECs; SSeCKS-null mice show PEC hyperplasia with increased nuclear cyclin D1 and worse glomerular disease.","method":"Co-immunoprecipitation from capsulated glomeruli; confocal microscopy; SSeCKS-null mouse model; nephrotoxic nephritis model; cell culture contact inhibition experiments","journal":"Laboratory investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP from primary tissue confirmed by KO mouse model with disease phenotype, multiple orthogonal methods","pmids":["22249313"],"is_preprint":false},{"year":2012,"finding":"SSeCKS contains a Src-binding domain (aa 153-166) homologous to the caveolin-1 Src-binding domain; this domain mediates SSeCKS-Src interaction, SSeCKS-enhanced Src activity, and sequestration of Src to caveolin-rich lipid rafts; SSeCKS suppresses adhesion-induced Src activation (SrcpoY416) and FAK-Y925 phosphorylation while increasing FAK(pY397) and cell adhesion to fibronectin; lipid raft sequestration of Src disengages Src from FAK-associated adhesion complexes.","method":"In silico domain identification; co-immunoprecipitation; lipid raft fractionation; SSeCKS domain deletion mutants; FAK and Src phosphorylation western blots; cell adhesion assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain deletion combined with biochemical fractionation and phosphorylation assays, single lab, multiple orthogonal methods","pmids":["22710722"],"is_preprint":false},{"year":2012,"finding":"AKAP12 depletion in zebrafish (akap12 morphants) causes severe hemorrhage due to disorganized interendothelial cell-cell adhesions; AKAP12 knockdown in endothelial cells reduces expression of PAK2 (actin cytoskeletal regulator) and AF6 (connector of intercellular adhesion molecules to actin); PAK2 or AF6 knockdown phenocopies AKAP12 depletion; overexpression of PAK2 and AF6 rescues hemorrhage in akap12 morphants.","method":"Zebrafish morpholino knockdown; in vivo time-lapse imaging; siRNA knockdown in cultured endothelial cells; PAK2/AF6 western blot; morphant rescue by PAK2+AF6 overexpression","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo zebrafish model with molecular rescue, complemented by cell culture mechanistic studies","pmids":["22192928"],"is_preprint":false},{"year":2012,"finding":"HDAC7 epigenetically silences AKAP12 in endothelial cells; siRNA depletion of HDAC7 causes H3 histone acetylation at the AKAP12 promoter, increasing AKAP12 mRNA and protein; elevated AKAP12 after HDAC7 depletion is responsible for inhibited migration and tube formation; AKAP12 mediates PKC-dependent phosphorylation of STAT3, which binds to the AKAP12 promoter and maintains elevated AKAP12 levels in a positive feedback loop.","method":"siRNA-mediated HDAC7 knockdown in HUVECs; proteomic analysis; ChIP for H3 acetylation; AKAP12 knockdown rescue; STAT3 ChIP at AKAP12 promoter; migration and tube formation assays","journal":"Angiogenesis","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP with functional rescue experiments, single lab, multiple orthogonal methods","pmids":["22584896"],"is_preprint":false},{"year":2013,"finding":"AKAP12/gravin promoter contains two functional HIF-binding sites; site-directed mutagenesis identified the distal HIF-binding site as essential for hypoxia-induced gravin expression; gravin gain-of-function inhibits microvascular endothelial tube formation ('braking' system for angiogenesis); gravin functionally couples to control endothelial barrier function in response to PKA agonists.","method":"Cloned gravin promoter reporter assays; site-directed mutagenesis of HIF-binding sites; gravin gain/loss-of-function in endothelial cells; tube formation assays; transendothelial resistance measurements","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — promoter mutagenesis with functional gain/loss-of-function, single lab, multiple orthogonal methods","pmids":["24029533"],"is_preprint":false},{"year":2014,"finding":"PKA compartmentalization by AKAP12 is required for cAMP-mediated endothelial barrier stabilization; siRNA depletion of AKAP12 significantly impairs endothelial barrier function; AKAP12 depletion redistributes PKA and Rac1 away from endothelial junctions and inactivates Rac1; TAT-Ahx-AKAPis peptide (competitive PKA-AKAP disruptor) destabilizes barrier and dampens forskolin/rolipram-mediated barrier enhancement.","method":"siRNA knockdown in microvascular endothelial cells; transendothelial electrical resistance; in vivo microvessel hydraulic conductivity; immunofluorescence for PKA/Rac1 localization; Rac1 activity assay; co-immunoprecipitation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown with in vivo validation, multiple readouts, competitive peptide inhibitor corroboration","pmids":["25188285"],"is_preprint":false},{"year":2014,"finding":"SSeCKS controls chemotaxis and lamellipodia formation by scaffolding phosphoinositides through its three MARCKS polybasic domains (PBD); loss of SSeCKS shifts leading edge from lamellipodia to filopodia-like extensions, enriches PIP3, Akt, PKC-ζ, Cdc42-GTP, and active Src at the leading edge, and recruits Frabin (Cdc42-GEF) via PIP2/3 binding; full-length SSeCKS or ΔPBD-deleted SSeCKS fails to rescue, whereas ΔSrc variant rescues, placing PIP scaffolding above Src-binding in chemotaxis control.","method":"SSeCKS-null MEF; domain deletion mutants (ΔPBD, ΔSrc); Frabin knockdown; leading-edge PIP3/Rac1/Cdc42 imaging; co-immunoprecipitation (negative for SSeCKS-Frabin/Cdc42/Rac1 interaction); PI3K constitutively-active epistasis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO MEF with domain-deletion epistasis and knockdown rescue, single lab, multiple orthogonal methods","pmids":["25356636"],"is_preprint":false},{"year":2014,"finding":"AKAP12 modulates meningeal EMT by regulating the TGF-β1-non-Smad-SNAI1 signaling pathway; AKAP12 expression in meningeal cells is regulated by integrated signals of TGF-β1, retinoic acid (RA), and oxygen tension; AKAP12-KO mice show impaired meningeal reconstruction after CNS injury.","method":"AKAP12-KO mice; CNS injury model; AKAP12 gain/loss-of-function in meningeal cells; TGF-β1/RA/oxygen tension manipulation; SNAI1 signaling analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with pathway analysis, single lab; pathway mechanistic detail (non-Smad SNAI1) not fully characterized in abstract","pmids":["25229625"],"is_preprint":false},{"year":2015,"finding":"Hypoxia selectively induces AKAP12 variant 2 (AKAP12v2) in metastatic melanoma; AKAP12v2 causes a shift in PKA-mediated phosphorylation events (identified by kinome-wide phosphoproteomics and MS) under hypoxia; this shift is due to changes in AKAP12 localization rather than structural differences between variants; the AKAP12-dependent phosphorylation shift alters tumor cell invasion and migration in vitro and metastasis in vivo.","method":"Kinome-wide phosphoproteomic and MS analysis; siRNA knockdown; gain-of-function expression of specific variant; in vitro invasion/migration assays; in vivo orthotopic melanoma model; immunofluorescence for localization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphoproteomics + MS + functional in vitro and in vivo validation, single lab, multiple orthogonal methods","pmids":["25792458"],"is_preprint":false},{"year":2016,"finding":"AKAP12 scaffolds PKA to mediate phosphorylation of ATR at Ser435, a modification required for cAMP-enhanced nucleotide excision repair (NER); UV exposure promotes ATR-directed phosphorylation of AKAP12 at S732, driving nuclear translocation of the AKAP12-ATR-pS435 complex; this complex recruits XPA to UV-damaged DNA and enhances 5' strand incision; preventing AKAP12-PKA or AKAP12-ATR interaction abrogates ATR-pS435, delays XPA recruitment, impairs NER, and increases UV-induced mutagenesis.","method":"siRNA knockdown; AKAP12-PKA interaction-blocking mutants; AKAP12-ATR interaction mutants; NER assay (5' incision); XPA recruitment ChIP; phosphorylation site mutagenesis; UV mutagenesis assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — defined mechanistic complex with site-specific mutagenesis, functional NER assay, and recruitment assay, single lab","pmids":["27683220"],"is_preprint":false},{"year":2019,"finding":"AKAP12 localizes to lamellipodia in migrating endothelial cells and to tip cells at the angiogenic front in postnatal retina; AKAP12 co-localizes with PKA type II-α regulatory subunit, Arp2/3 complex components, and VASP; AKAP12 deletion results in defective vascular plexus extension; VEGF-stimulated PKA-dependent phosphorylation of VASP at Ser157 requires AKAP12, demonstrated by co-localization of phospho-Ser157 VASP with AKAP12 at the leading edge.","method":"siRNA knockdown in human endothelial cells; AKAP12-/- mice; immunoprecipitation and mass spectrometry; postnatal retinal vascular imaging; VASP phosphorylation western blot; immunofluorescence co-localization","journal":"Acta physiologica","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse model with MS-identified complex, functional vascular phenotype, and phosphorylation assay, multiple orthogonal methods","pmids":["31162891"],"is_preprint":false},{"year":2020,"finding":"AKAP12 loss in endothelial cells causes upregulation/activation of the Rho kinase pathway and increased endothelial permeability with dysregulation of ZO-1/Claudin-5; Rho kinase inhibitor Y-27632 reverses increased permeability in AKAP12-deficient cells and tightens the BBB in Akap12 knockout mice after stroke, placing AKAP12 upstream of the Rho kinase pathway in BBB maintenance.","method":"siRNA knockdown in cultured cerebral endothelial cells; Akap12 KO mice; stroke (focal ischemia) model; Rho kinase activity assay; permeability assay; Rho kinase inhibitor rescue; ZO-1/Claudin-5 western blot","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse model corroborated by cell culture knockdown with pharmacological pathway rescue, multiple orthogonal methods","pmids":["33260683"],"is_preprint":false},{"year":2020,"finding":"Notch signaling suppresses Akap12 expression during renal tubule morphogenesis; loss of Notch signaling increases Akap12 expression and results in abnormally long primary cilia; ectopic Akap12 expression phenocopies Notch loss (long cilia, defective lumen formation); Akap12 inhibits Notch-mediated transcription, suggesting a negative feedback loop.","method":"Dominant-negative mastermind-like (dnMaml) expression in renal epithelia; Akap12 ectopic expression; primary cilia length measurement; organoid (spheroid) lumen formation assay; Notch transcriptional reporter assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with phenotypic rescue and transcriptional reporter, single lab","pmids":["32474964"],"is_preprint":false},{"year":2022,"finding":"HDAC6 directly interacts with AKAP12 and deacetylates it at K526/K531; deacetylation of AKAP12 at K531 by HDAC6 increases its ubiquitination level, facilitating proteasome-dependent degradation; deletion of AKAP12 in HDAC6-knockdown cells restores cell motility defects and reactivates PKC isoforms, placing AKAP12 downstream of HDAC6-mediated degradation in colon cancer metastasis control.","method":"Proteomic analysis; co-immunoprecipitation of HDAC6-AKAP12; site-specific acetylation mapping (K526/K531); ubiquitination assay; AKAP12 deletion rescue in HDAC6-KD cells; PKC activity assays","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — deacetylation substrate mapping with ubiquitination consequence and epistatic rescue, single lab, multiple orthogonal methods","pmids":["36122629"],"is_preprint":false},{"year":2024,"finding":"AKAP12 overexpression in cardiac myocytes reduces total intracellular cAMP levels through PDE8 (not PDE4D); AKAP12-overexpressing mice show reduced cardiomyocyte contractility and impaired calcium handling in response to isoproterenol, reversed by selective PDE8 inhibitor (PF-04957325); AKAP12OX mice develop systolic dysfunction and left ventricular enlargement; patients with end-stage heart failure show upregulated AKAP12.","method":"Luciferase-based cAMP biosensor (GloSensor) in AC16 cardiomyocytes; adult primary cardiomyocyte contractility and calcium imaging; AKAP12 cardiac-specific overexpression mouse model; PDE8 inhibitor rescue; left ventricular function echocardiography","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — real-time cAMP measurement, KO rescue with specific PDE8 inhibitor, in vivo mouse model, and human patient validation; multiple orthogonal methods","pmids":["38506047"],"is_preprint":false},{"year":1999,"finding":"SSeCKS/clone 72 contains a PKA RII-binding domain (aa 1495-1524) identified by deletion mutagenesis, confirming it is an AKAP; PKC-induced serine phosphorylation of SSeCKS causes rapid translocation to perinuclear sites, coincident with retraction of stellate processes in mesangial cells; ablation of SSeCKS by antisense retroviral vectors induces fibroblastic morphology, thick longitudinal stress fibers, and repositioning of vinculin-associated focal complexes.","method":"Deletion mutagenesis for RII binding; retroviral antisense vector knockdown; PKC activation with phorbol ester; bis-indolylmaleimide PKC inhibitor; immunofluorescence for SSeCKS, F-actin, vinculin","journal":"Journal of cell science / European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — RII-binding domain mutagenesis plus antisense knockdown with defined cytoskeletal phenotypes, replicated across two independent studies","pmids":["9885289","10469144"],"is_preprint":false},{"year":2002,"finding":"SSeCKS tyrosine phosphorylation by mitogens (EGF, PDGF, serum) is FAK-dependent: FAK-deficient cells cannot phosphorylate SSeCKS upon EGF stimulation, rescued by re-expression of wild-type FAK but not FAK-Y397 mutant; purified FAK or Src fail to directly phosphorylate SSeCKS in vitro; phosphorylation is independent of Src/Fyn/Yes/Abl; unphosphorylated bacterially expressed SSeCKS co-sediments with F-actin; tyrosine phosphorylation modulates SSeCKS-actin interaction.","method":"FAK-/- MEF complementation; in vitro kinase assays with purified enzymes; [32P] metabolic labeling; F-actin co-sedimentation ultracentrifugation; immunofluorescence; coprecipitation with biotin-phalloidin","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution plus FAK-/- genetic rescue with mutagenesis and F-actin sedimentation, single lab","pmids":["12083796"],"is_preprint":false},{"year":2008,"finding":"AKAP12/gravin is selectively required for resensitization and recycling of the beta2-adrenergic receptor: AKAP12 knockdown in A431 or HEK293 cells abolishes receptor resensitization, while AKAP5 knockdown does not; AKAP5 knockdown abolishes Erk1/2 activation downstream of beta2AR while AKAP12 knockdown does not, demonstrating non-redundant pathway segregation between the two AKAPs.","method":"siRNA knockdown of AKAP5 or AKAP12 in A431 and HEK293 cells; beta2AR resensitization assay; ERK1/2 phosphorylation assay; receptor recycling assay","journal":"Journal of molecular signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal siRNA knockdown in two cell lines with specific functional readouts, clean dissection of non-redundant roles","pmids":["19055733"],"is_preprint":false},{"year":2011,"finding":"AKAP12 forms higher-order homo-oligomers (behaving as dimers or tetramers ~840 kDa by steric-exclusion chromatography); both N-terminal (aa 1-840) and C-terminal (aa 840-1782) regions independently form dimers; AKAP12 and AKAP5 form hetero-oligomers demonstrated by affinity chromatography and steric-exclusion chromatography; beta-adrenergic agonist stimulation increases AKAP5-AKAP12 docking 4-fold; AKAP12 overexpression potentiates AKAP5-mediated ERK1/2 activation.","method":"SDS-PAGE/urea denaturation; steric-exclusion chromatography; affinity chromatography with immobilized AKAPs; co-immunoprecipitation; ERK1/2 phosphorylation assay with agonist stimulation","journal":"Journal of molecular signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — affinity chromatography and steric-exclusion chromatography with functional ERK readout, single lab","pmids":["21554706","21831305"],"is_preprint":false},{"year":2017,"finding":"Stromal SSeCKS/AKAP12 suppresses metastatic peritoneal colonization by attenuating secretion of Cxcl9/10 from peritoneal membrane fibroblasts; SSeCKS-null peritoneal fibroblasts exhibit senescence (SA-β-gal, p21, p16) and secrete elevated Cxcl10 in response to inflammatory mediators; Cxcr3 knockdown abrogates enhanced chemotaxis to KO peritoneal fluid; SSeCKS scaffolding-site mutants and kinase inhibitors show PKC, PKA, and PI3K/Akt pathways are responsible for Cxcl10 secretion control.","method":"SSeCKS-null mice; peritoneal fluid adoptive transfer; Cxcr3 knockdown; Cxcl10 neutralizing antibody; conditioned media from KO peritoneal membrane fibroblasts; SSeCKS scaffolding-site mutants; kinase inhibitors; senescence markers","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse adoptive transfer plus mechanistic domain mutant and inhibitor dissection, multiple orthogonal methods","pmids":["29050279"],"is_preprint":false},{"year":2018,"finding":"SSeCKS/AKAP12 in lung fibroblasts suppresses metastatic melanoma colonization by attenuating Src/STAT3-dependent senescence-associated secretory phenotype; SSeCKS Src-scaffolding domain is required to attenuate IFNα-induced Stat3 activation in KO lung fibroblasts; KO lung endothelial cells exhibit increased E-Selectin levels facilitating melanoma adhesion.","method":"SSeCKS-null syngeneic mouse hosts; lung fibroblast conditioned media; co-injection of cancer cells with KO or WT lung fibroblasts; Stat3 activation assays; SSeCKS Src-scaffolding domain mutants; E-Selectin western blot","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with domain mutant epistasis, single lab, specific pathway readouts","pmids":["30323895"],"is_preprint":false},{"year":2018,"finding":"HDAC3 directly binds within the intron-1 region of AKAP12 and this binding is indispensable for HDAC3-mediated inhibition of AKAP12 expression; HDAC3 inhibitors (TSA, RGFP966) restore AKAP12 expression; AKAP12 knockdown increases PI3K/AKT signaling activity, establishing PI3K/AKT as downstream of AKAP12 in colorectal cancer cells.","method":"ChIP for HDAC3 binding at AKAP12 intron-1; HDAC3 inhibitor treatment (TSA, RGFP966); AKAP12 siRNA knockdown; PI3K/AKT pathway western blot; colony formation and migration assays","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP binding evidence with pharmacological inhibitor validation, single lab","pmids":["29484387"],"is_preprint":false},{"year":2015,"finding":"SSeCKS expression is decreased in differentiated Schwann cells; long-term SSeCKS knockdown changes Schwann cell morphology, accelerates myelin gene expression induced by cAMP, and enhances myelination in Schwann cell-DRG co-culture; SSeCKS suppression promotes Akt (Ser473) phosphorylation in cAMP-treated Schwann cells, identifying SSeCKS as a negative regulator of Schwann cell myelination.","method":"SSeCKS siRNA/antisense knockdown in Schwann cells; DRG co-culture myelination assay; myelin gene expression (RT-PCR); Akt phosphorylation western blot","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with functional myelination assay and signaling readout, single lab","pmids":["19757038"],"is_preprint":false}],"current_model":"AKAP12/SSeCKS/Gravin is a large multivalent scaffold protein that spatiotemporally organizes PKA, PKC, calmodulin, cyclins D1/E, Src, phosphoinositides, and beta2-adrenergic receptors to control cell-cycle G1→S progression (by cytoplasmic sequestration of cyclin D1 released upon PKC-dependent phosphorylation), actin-based cytoskeletal architecture (by regulating RhoA/Cdc42/Rac1 GTPase balance and PIP2/3 scaffolding), metastatic signaling (by scaffolding PKC away from the Raf/MEK/ERK axis and sequestering Src to lipid rafts to disengage FAK), receptor resensitization (by PKA-dependent phosphorylation at its AKAP domain enabling β2AR re-association and recycling), blood-brain/blood-retinal barrier formation (by suppressing HIF-1α/VEGF and promoting angiopoietin-1 in astrocytes, and by compartmentalizing PKA-VASP signaling at endothelial leading edges), cardiac cAMP homeostasis (by coupling to PDE8 to limit PKA signaling downstream of β2AR), and DNA repair (by scaffolding PKA-mediated phosphorylation of ATR-S435 to recruit XPA to UV damage), while being subject to epigenetic repression (HDAC3/HDAC7-mediated transcriptional silencing; HDAC6-mediated deacetylation triggering ubiquitin-proteasomal degradation) and transcriptional downregulation in oncogenic contexts via Src-driven recruitment of HDAC1 to a USF1-Sp1/Sp3-TFII-I promoter complex."},"narrative":{"mechanistic_narrative":"AKAP12 (SSeCKS/Gravin) is a large multivalent scaffold protein that spatiotemporally compartmentalizes kinases, cytoskeletal regulators, and signaling lipids to govern cytoskeletal architecture, cell-cycle progression, receptor recycling, and barriergenesis [PMID:9744295, PMID:10982843, PMID:14657015, PMID:12808449]. Its scaffolding logic is built from defined, phosphorylation-gated binding modules: it carries a PKA RII-binding domain establishing it as a bona fide AKAP [PMID:9885289, PMID:10469144], cyclin-binding (CY) motifs that overlap PKC phosphorylation sites (Ser507/515) so that PKC phosphorylation releases cytoplasmically sequestered cyclin D1 for nuclear translocation [PMID:10982843, PMID:22249313], calmodulin-binding sites antagonized by PKC phosphorylation [PMID:11820772], and direct PKCα-binding motifs through which AKAP12 binds and dampens PKC activity to restrain Rb-mediated senescence and cytoskeletal remodeling [PMID:21099353, PMID:21903576]. Through this architecture AKAP12 organizes actin-based cytoskeleton and adhesion, sequestering Src to caveolin-rich lipid rafts to disengage FAK and suppressing RhoA/Cdc42 to block podosome formation, and scaffolding phosphoinositides via MARCKS-like polybasic domains to direct lamellipodial chemotaxis [PMID:9744295, PMID:16547152, PMID:22710722, PMID:25356636]. It functions as a tumor and metastasis suppressor by attenuating Raf/MEK/ERK signaling away from a sequestered PKC pool, reducing MMP-2, VEGF, and invasion [PMID:9187136, PMID:16740695, PMID:20018890]. In endothelial and astrocytic compartments AKAP12 drives blood-brain/blood-retinal barrier formation by suppressing HIF-1α/VEGF and inducing angiopoietin-1, and by compartmentalizing PKA-VASP/Rac1 signaling at endothelial junctions and leading edges while restraining the Rho kinase pathway [PMID:12808449, PMID:17442832, PMID:31162891, PMID:33260683]. As an AKAP it phosphorylation-dependently re-associates with the β2-adrenergic receptor to enable resensitization and recycling [PMID:14657015, PMID:19055733], and in cardiomyocytes couples to PDE8 to limit intracellular cAMP and contractility [PMID:38506047]; it also scaffolds PKA-mediated phosphorylation of ATR-S435 to recruit XPA during nucleotide excision repair [PMID:27683220]. AKAP12 expression and stability are tightly controlled, undergoing epigenetic silencing by HDAC3/HDAC7 and Src-driven HDAC1 recruitment, and HDAC6-mediated deacetylation that triggers ubiquitin-proteasomal degradation [PMID:17626016, PMID:20568114, PMID:22584896, PMID:36122629, PMID:29484387].","teleology":[{"year":1997,"claim":"Establishing that re-expression of SSeCKS reverses oncogenic transformation answered whether this protein is a functional tumor suppressor and whether it acts on Src directly.","evidence":"Tetracycline-regulated SSeCKS re-expression in v-Src-transformed NIH3T3 with soft agar, invasion, and kinase assays","pmids":["9187136"],"confidence":"High","gaps":["Did not identify the molecular target through which SSeCKS suppresses transformation downstream of intact Src activity","Did not define direct binding partners"]},{"year":1998,"claim":"Demonstrating that ectopic SSeCKS reorganizes the cortical cytoskeleton established its primary role as a controller of actin-based architecture and adhesion.","evidence":"Inducible expression in NIH3T3 with immunofluorescence, fractionation, and cytoskeletal inhibitor studies","pmids":["9744295"],"confidence":"High","gaps":["Did not identify the signaling molecules scaffolded to drive cytoskeletal changes","Mechanism linking FAK phosphorylation to morphology unresolved"]},{"year":1999,"claim":"Identification of the PKA RII-binding domain and PKC-triggered translocation defined SSeCKS as an AKAP whose localization is phosphorylation-regulated.","evidence":"Deletion mutagenesis for RII binding and antisense knockdown with phorbol ester in mesangial cells","pmids":["9885289","10469144"],"confidence":"High","gaps":["Did not link RII anchoring to a specific downstream PKA substrate","Functional consequence of perinuclear translocation undefined"]},{"year":2000,"claim":"Mapping cyclin-binding motifs overlapping PKC phosphorylation sites answered how SSeCKS couples kinase signaling to cell-cycle control via cyclin D1 sequestration.","evidence":"In vitro CY-domain binding, site-directed mutagenesis, confocal imaging, and pRb assays in NIH3T3","pmids":["10982843"],"confidence":"High","gaps":["Forced cyclin D1 re-expression did not rescue G1 arrest, indicating uncharacterized additional mechanisms","ERK2-dependent cyclin D1 downregulation mechanism not fully resolved"]},{"year":2002,"claim":"Demonstrating calmodulin binding and phosphorylation-attenuated cyclin binding established that PKC phosphorylation is a master switch modulating multiple SSeCKS scaffolding outputs.","evidence":"In vitro binding of bacterial SSeCKS fragments with PKC pre-phosphorylation and deletion mapping","pmids":["11820772"],"confidence":"High","gaps":["Cellular consequence of CaM binding not directly demonstrated","Single-lab in vitro reconstitution"]},{"year":2002,"claim":"Showing FAK-dependent, indirect tyrosine phosphorylation of SSeCKS clarified how mitogenic signaling modulates its actin association.","evidence":"FAK-/- MEF complementation, in vitro kinase assays, and F-actin co-sedimentation","pmids":["12083796"],"confidence":"High","gaps":["The actual kinase phosphorylating SSeCKS downstream of FAK was not identified","Tyrosine sites on SSeCKS not mapped"]},{"year":2003,"claim":"Defining gravin-β2AR association through its AKAP domain and PKA phosphorylation answered how an AKAP scaffold enables receptor resensitization.","evidence":"Mutagenesis, metabolic labeling, Co-IP, and resensitization assays","pmids":["14657015"],"confidence":"High","gaps":["Did not establish whether other receptors use the same docking mechanism","Dynamics of association/dissociation in cells incompletely resolved"]},{"year":2003,"claim":"Demonstrating SSeCKS-driven VEGF suppression and angiopoietin-1 induction in astrocytes established its role in blood-brain barrier differentiation.","evidence":"Astrocyte overexpression, conditioned media transfer, angiogenesis and sucrose permeability assays in vivo and in vitro","pmids":["12808449"],"confidence":"High","gaps":["Molecular mechanism of VEGF suppression not yet defined","Endothelial signaling target of secreted factors unresolved"]},{"year":2004,"claim":"Characterization of three promoter-driven isoforms with distinct targeting (including myristoylation-driven ER localization) revealed isoform-specific subcellular compartmentalization.","evidence":"Comparative genomics, reporter assays, GFP chimeras, and myristoylation mutagenesis","pmids":["15496411"],"confidence":"High","gaps":["Functional distinction between isoforms not established","ER-localized AKAP12α role undefined"]},{"year":2005,"claim":"Mapping NLS, nuclear-exclusion, and peripheral targeting domains established a hierarchy of localization signals governing AKAP12 distribution.","evidence":"Cross-species sequence analysis, deletion mapping, GFP chimera imaging, and fractionation","pmids":["15923193"],"confidence":"Medium","gaps":["No functional consequence of differential localization directly demonstrated","Conditions triggering nuclear import not identified"]},{"year":2006,"claim":"Placing SSeCKS downstream of Src but upstream of RhoA/Cdc42 in podosome suppression connected its tumor-suppressor activity to GTPase-mediated cytoskeletal remodeling.","evidence":"Inducible expression, GTPase activity assays, constitutively active GTPase rescue, and invasion assays","pmids":["16547152"],"confidence":"High","gaps":["Mechanism by which SSeCKS lowers RhoA/Cdc42 activity not defined","Direct GTPase regulators involved unidentified"]},{"year":2006,"claim":"Showing VEGF re-expression partially reverses metastasis suppression established VEGF/angiogenic gene control as a key effector of SSeCKS metastasis suppression in vivo.","evidence":"Inducible expression, spontaneous/experimental metastasis models, and VEGF isoform rescue","pmids":["16740695"],"confidence":"High","gaps":["Partial reversal indicates VEGF-independent mechanisms remain","Transcriptional mechanism of VEGF/HIF-1α regulation not resolved here"]},{"year":2007,"claim":"Demonstrating AKAP12 enhances pVHL/PHD2-dependent HIF-1α degradation answered how it suppresses VEGF and promotes blood-retinal barrier formation.","evidence":"Astrocyte overexpression, Co-IP of HIF-1α with pVHL/PHD2, and conditioned media tight-junction assays","pmids":["17442832"],"confidence":"High","gaps":["Whether AKAP12 directly contacts the HIF degradation machinery is not established","Mechanism enhancing the pVHL/PHD2 interaction unresolved"]},{"year":2007,"claim":"Defining v-Src-driven HDAC1/USF1/Sp1-Sp3/TFII-I promoter repression revealed the transcriptional mechanism by which oncogenic signaling silences SSeCKS.","evidence":"Promoter deletion, ChIP, HDAC1 siRNA, EMSA, and TFII-I phosphorylation mutants","pmids":["17626016","20568114"],"confidence":"High","gaps":["Did not establish how Src activates this promoter complex mechanistically","Generality across cell types untested"]},{"year":2008,"claim":"Tracing an AKAP12→PKCζ→Rho kinase→VEGF/TSP-1 axis and the prostatic AKT phenotype connected AKAP12 loss to elevated angiogenic and PI3K/AKT signaling in tissue.","evidence":"Conditioned media with PKCζ siRNA and Rho kinase inhibitor; SSeCKS-null prostate histology with pAKT blots","pmids":["18397319","18593908"],"confidence":"Medium","gaps":["Indirect conditioned-media readout for the PKCζ pathway","Mechanism linking AKAP12 to AKT attenuation in prostate not defined"]},{"year":2008,"claim":"Reciprocal siRNA dissection of AKAP12 versus AKAP5 established non-redundant segregation of β2AR resensitization (AKAP12) from ERK activation (AKAP5).","evidence":"Reciprocal siRNA knockdown in A431 and HEK293 with resensitization, recycling, and ERK assays","pmids":["19055733"],"confidence":"High","gaps":["Structural basis for pathway segregation not determined","Whether the two AKAPs physically interact addressed only later"]},{"year":2009,"claim":"Showing SSeCKS attenuates Raf/MEK/ERK via its PKC-binding domain to reduce MMP-2 and invasion established the kinase-scaffolding basis of its anti-invasive activity.","evidence":"Inducible expression, constitutively active kinase rescue, domain deletion, and actin perturbation","pmids":["20018890"],"confidence":"High","gaps":["Direct demonstration of PKC-Raf disengagement on the scaffold not shown","Link between actin and MEK/ERK attenuation mechanistically incomplete"]},{"year":2010,"claim":"Defining premature senescence in AKAP12-null MEF through PKCα/δ scaffolding revealed AKAP12 control over Rb-mediated aging and cytokinesis.","evidence":"KO MEF with PKC activity assays, MEK inhibitor epistasis, and senescence/polyploidy quantification","pmids":["21099353"],"confidence":"High","gaps":["Direct PKCα/δ binding shown definitively in a later study","Connection between Lats1 downregulation and PKCδ not fully mapped"]},{"year":2011,"claim":"Mapping two PKCα-binding motifs and showing binding inhibits PKC activity provided the biochemical basis for AKAP12 as a PKC-sequestering scaffold.","evidence":"In vitro motif-defined binding and kinase assays plus KO MEF rescue with deletion constructs","pmids":["21903576"],"confidence":"High","gaps":["Whether all PKC isoforms share the same binding mode unresolved","Single-lab in vitro reconstitution"]},{"year":2011,"claim":"Demonstrating AKAP12 homo-oligomerization and hetero-oligomerization with AKAP5 indicated higher-order scaffold assembly that potentiates ERK signaling.","evidence":"Steric-exclusion and affinity chromatography, Co-IP, and ERK assays with agonist","pmids":["21554706","21831305"],"confidence":"Medium","gaps":["Physiological role of oligomerization not established in vivo","Stoichiometry and structural basis undefined"]},{"year":2012,"claim":"Identifying the caveolin-1-like Src-binding domain that sequesters Src to lipid rafts explained how SSeCKS disengages Src from FAK adhesion complexes.","evidence":"Domain identification, Co-IP, lipid raft fractionation, deletion mutants, and FAK/Src phosphorylation assays","pmids":["22710722"],"confidence":"High","gaps":["Direct structural verification of raft targeting absent","How Src sequestration alters adhesion dynamics over time unresolved"]},{"year":2012,"claim":"Confirming cytoplasmic cyclin D1 sequestration in quiescent epithelial cells with a KO disease phenotype validated the cyclin-control model in vivo.","evidence":"Co-IP from primary glomeruli, confocal imaging, and SSeCKS-null nephritis model","pmids":["22249313"],"confidence":"High","gaps":["PKC kinase identity driving release in vivo not specified","Generalizability beyond glomerular epithelium untested"]},{"year":2012,"claim":"Linking AKAP12 to PAK2/AF6-dependent endothelial junction integrity in zebrafish established its requirement for vascular barrier maintenance in vivo.","evidence":"Morpholino knockdown with in vivo imaging, cell culture siRNA, and PAK2+AF6 rescue","pmids":["22192928"],"confidence":"High","gaps":["Mechanism by which AKAP12 controls PAK2/AF6 expression not defined","Direct binding to junctional components untested"]},{"year":2012,"claim":"Demonstrating HDAC7-mediated silencing and a PKC-STAT3 positive feedback loop revealed epigenetic control of AKAP12 in endothelial cells.","evidence":"HDAC7 siRNA, H3 acetylation ChIP, STAT3 ChIP at the promoter, and migration/tube assays","pmids":["22584896"],"confidence":"High","gaps":["Direct STAT3-AKAP12 promoter regulatory architecture incompletely mapped","Whether feedback operates in other cell types untested"]},{"year":2013,"claim":"Identifying functional HIF-binding sites in the gravin promoter and a barrier-stabilizing role connected hypoxia sensing to AKAP12-mediated angiogenic braking.","evidence":"Promoter reporter assays, HIF-site mutagenesis, gain/loss-of-function, and transendothelial resistance","pmids":["24029533"],"confidence":"High","gaps":["Interplay between HIF-driven induction and AKAP12-driven HIF-1α suppression unresolved","Single-lab promoter dissection"]},{"year":2014,"claim":"Showing AKAP12-anchored PKA and Rac1 are required for cAMP-mediated endothelial barrier stabilization defined a junctional compartmentalization mechanism.","evidence":"siRNA knockdown, transendothelial resistance, in vivo hydraulic conductivity, Rac1 assays, and AKAP-disruptor peptide","pmids":["25188285"],"confidence":"High","gaps":["Direct PKA substrate at junctions not identified here","Link between PKA anchoring and Rac1 activation mechanistically incomplete"]},{"year":2014,"claim":"Establishing phosphoinositide scaffolding via MARCKS polybasic domains, ranked above Src binding, defined how SSeCKS directs lamellipodial chemotaxis.","evidence":"KO MEF, ΔPBD/ΔSrc deletion epistasis, Frabin knockdown, and leading-edge PIP3/GTPase imaging","pmids":["25356636"],"confidence":"High","gaps":["Direct lipid-binding affinities not quantified","How PBD scaffolding spatially restricts Cdc42-GEF activity unresolved"]},{"year":2014,"claim":"Linking AKAP12 to TGF-β1-non-Smad-SNAI1 signaling in meningeal EMT established a role in CNS injury reconstruction.","evidence":"AKAP12-KO mice with CNS injury model and gain/loss-of-function under TGF-β1/RA/oxygen manipulation","pmids":["25229625"],"confidence":"Medium","gaps":["Non-Smad SNAI1 mechanistic detail not fully characterized","Direct AKAP12 scaffolding role in the pathway undefined"]},{"year":2015,"claim":"Showing hypoxia induces AKAP12 variant 2 to shift PKA-mediated phosphorylation events connected localization-driven scaffold variation to metastatic behavior.","evidence":"Kinome-wide phosphoproteomics/MS, siRNA, variant gain-of-function, and orthotopic melanoma model","pmids":["25792458"],"confidence":"High","gaps":["Specific PKA substrates driving the invasive shift not all defined","Mechanism of variant-specific localization unresolved"]},{"year":2016,"claim":"Defining the AKAP12-PKA-ATR-S435 complex that recruits XPA established a direct role for AKAP12 scaffolding in nucleotide excision repair.","evidence":"siRNA, interaction-blocking mutants, NER incision assay, XPA recruitment, and UV mutagenesis assay","pmids":["27683220"],"confidence":"High","gaps":["Structural organization of the nuclear complex undefined","How UV signals to ATR-directed AKAP12 phosphorylation incompletely mapped"]},{"year":2017,"claim":"Demonstrating stromal SSeCKS suppresses peritoneal colonization via Cxcl9/10 control implicated scaffold-regulated stromal secretion in metastasis suppression.","evidence":"SSeCKS-null mice, peritoneal fluid adoptive transfer, Cxcr3 knockdown, scaffolding-site mutants, and kinase inhibitors","pmids":["29050279"],"confidence":"High","gaps":["Relative contribution of PKC/PKA/PI3K pathways to chemokine control not separated","Link between fibroblast senescence and chemokine output mechanistically incomplete"]},{"year":2018,"claim":"Showing fibroblast SSeCKS attenuates Src/STAT3-dependent SASP extended its stromal metastasis-suppressor role to lung colonization.","evidence":"SSeCKS-null syngeneic hosts, co-injection assays, STAT3 activation, Src-scaffolding domain mutants, and E-Selectin blots","pmids":["30323895"],"confidence":"Medium","gaps":["Direct Src-STAT3 scaffolding on AKAP12 not biochemically resolved","Endothelial E-Selectin regulation mechanism undefined"]},{"year":2018,"claim":"Identifying HDAC3 binding at AKAP12 intron-1 as repressive, with PI3K/AKT as a downstream effector, added a second epigenetic silencing mechanism in colorectal cancer.","evidence":"HDAC3 ChIP, inhibitor treatment, AKAP12 siRNA, and PI3K/AKT blots","pmids":["29484387"],"confidence":"Medium","gaps":["How HDAC3 represses from an intronic site mechanistically unresolved","Direct vs indirect AKAP12 control of PI3K/AKT undefined"]},{"year":2019,"claim":"Localizing AKAP12 with PKA-RIIα, Arp2/3, and VASP at endothelial tip-cell leading edges defined a PKA-VASP compartment driving angiogenic sprouting.","evidence":"siRNA, AKAP12-/- mice, IP-MS, postnatal retinal imaging, and VASP-Ser157 phosphorylation assays","pmids":["31162891"],"confidence":"High","gaps":["Direct AKAP12-VASP contact not established","Spatial coupling of Arp2/3 to the scaffold mechanistically incomplete"]},{"year":2020,"claim":"Placing AKAP12 upstream of Rho kinase in BBB maintenance, with pharmacological rescue after stroke, connected AKAP12 loss to junctional permeability through ROCK activation.","evidence":"siRNA in cerebral endothelial cells, Akap12 KO stroke model, Rho kinase assays, and Y-27632 rescue","pmids":["33260683"],"confidence":"High","gaps":["Mechanism by which AKAP12 restrains Rho kinase not defined","Link to ZO-1/Claudin-5 regulation mechanistically incomplete"]},{"year":2020,"claim":"Showing Notch suppresses Akap12 and that ectopic Akap12 causes ciliary/lumen defects revealed a Notch-AKAP12 negative feedback loop in renal morphogenesis.","evidence":"dnMaml expression, Akap12 ectopic expression, cilia length and lumen assays, and Notch reporter","pmids":["32474964"],"confidence":"Medium","gaps":["Mechanism by which Akap12 inhibits Notch transcription undefined","Direct molecular link to ciliary length control unresolved"]},{"year":2022,"claim":"Identifying HDAC6 deacetylation of AKAP12 at K531 as a trigger for ubiquitin-proteasomal degradation revealed post-translational control coupling AKAP12 stability to PKC reactivation in metastasis.","evidence":"Proteomics, HDAC6-AKAP12 Co-IP, acetylation site mapping, ubiquitination assay, and AKAP12 deletion rescue","pmids":["36122629"],"confidence":"High","gaps":["E3 ligase mediating AKAP12 ubiquitination not identified","How acetylation status shifts under physiological cues unresolved"]},{"year":2024,"claim":"Demonstrating AKAP12 couples to PDE8 to limit cardiac cAMP, with a heart-failure phenotype and human validation, defined a cardiac cAMP-homeostasis role.","evidence":"GloSensor cAMP biosensor, primary cardiomyocyte contractility/calcium imaging, cardiac-specific overexpression mice, PDE8 inhibitor rescue, and human failing-heart samples","pmids":["38506047"],"confidence":"High","gaps":["Direct AKAP12-PDE8 binding architecture not detailed","Whether endogenous AKAP12 loss has reciprocal cardiac effects untested"]},{"year":null,"claim":"How the many AKAP12 scaffolding modules are integrated structurally into a single multivalent platform, and how isoform/localization choice selects among its competing signaling outputs, remains unresolved.","evidence":"No structural or integrated-systems study in the available corpus resolves module coordination","pmids":[],"confidence":"Low","gaps":["No structural model of full-length AKAP12 or its assembled complexes","Rules selecting between PKA, PKC, cyclin, Src, and PIP scaffolding outputs in a given context unknown","In vivo stoichiometry of competing partner binding undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,5,17,27,33]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[17,16,19,32]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,34,24]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[24]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[2,18,19]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,33,24]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,19,24]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,27]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,18]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,15,35,32]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[2,16,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,10,31,37]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[27]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[20,23,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,25,28,30]}],"complexes":[],"partners":["PRKACA","PRKCA","SRC","CCND1","ATR","AKAP5","ADRB2","B4GALT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q02952","full_name":"A-kinase anchor protein 12","aliases":["A-kinase anchor protein 250 kDa","AKAP 250","Gravin","Myasthenia gravis autoantigen"],"length_aa":1782,"mass_kda":191.5,"function":"Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC)","subcellular_location":"Cytoplasm, cell cortex; Cytoplasm, cytoskeleton; Membrane","url":"https://www.uniprot.org/uniprotkb/Q02952/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AKAP12","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000131016","cell_line_id":"CID000960","localizations":[{"compartment":"membrane","grade":3},{"compartment":"big_aggregates","grade":2},{"compartment":"cytoplasmic","grade":2}],"interactors":[{"gene":"HSPA12A","stoichiometry":4.0},{"gene":"GAPDH","stoichiometry":0.2},{"gene":"LDHA","stoichiometry":0.2},{"gene":"ORC4","stoichiometry":0.2},{"gene":"PRKACA","stoichiometry":0.2},{"gene":"PRKAR2A","stoichiometry":0.2},{"gene":"FHL1","stoichiometry":0.2},{"gene":"TRAP1","stoichiometry":0.2},{"gene":"ACADM","stoichiometry":0.2},{"gene":"CTNNB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000960","total_profiled":1310},"omim":[{"mim_id":"604698","title":"A-KINASE ANCHOR PROTEIN 12; AKAP12","url":"https://www.omim.org/entry/604698"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/AKAP12"},"hgnc":{"alias_symbol":["AKAP250","SSeCKS"],"prev_symbol":[]},"alphafold":{"accession":"Q02952","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02952","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q02952-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q02952-F1-predicted_aligned_error_v6.png","plddt_mean":40.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AKAP12","jax_strain_url":"https://www.jax.org/strain/search?query=AKAP12"},"sequence":{"accession":"Q02952","fasta_url":"https://rest.uniprot.org/uniprotkb/Q02952.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q02952/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02952"}},"corpus_meta":[{"pmid":"12808449","id":"PMC_12808449","title":"SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12808449","citation_count":388,"is_preprint":false},{"pmid":"11454719","id":"PMC_11454719","title":"The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11454719","citation_count":111,"is_preprint":false},{"pmid":"10982843","id":"PMC_10982843","title":"SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10982843","citation_count":107,"is_preprint":false},{"pmid":"14657015","id":"PMC_14657015","title":"Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14657015","citation_count":97,"is_preprint":false},{"pmid":"21779438","id":"PMC_21779438","title":"Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.","date":"2010","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21779438","citation_count":86,"is_preprint":false},{"pmid":"17442832","id":"PMC_17442832","title":"AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17442832","citation_count":86,"is_preprint":false},{"pmid":"15258566","id":"PMC_15258566","title":"AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15258566","citation_count":86,"is_preprint":false},{"pmid":"20018890","id":"PMC_20018890","title":"SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20018890","citation_count":78,"is_preprint":false},{"pmid":"29633510","id":"PMC_29633510","title":"Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29633510","citation_count":77,"is_preprint":false},{"pmid":"12133808","id":"PMC_12133808","title":"The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .","date":"2002","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/12133808","citation_count":75,"is_preprint":false},{"pmid":"9744295","id":"PMC_9744295","title":"Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.","date":"1998","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/9744295","citation_count":75,"is_preprint":false},{"pmid":"22684366","id":"PMC_22684366","title":"Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.","date":"2012","source":"Cancer metastasis reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22684366","citation_count":73,"is_preprint":false},{"pmid":"9187136","id":"PMC_9187136","title":"Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9187136","citation_count":69,"is_preprint":false},{"pmid":"18593908","id":"PMC_18593908","title":"Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18593908","citation_count":68,"is_preprint":false},{"pmid":"16740695","id":"PMC_16740695","title":"SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16740695","citation_count":67,"is_preprint":false},{"pmid":"18199717","id":"PMC_18199717","title":"Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.","date":"2008","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18199717","citation_count":65,"is_preprint":false},{"pmid":"22811901","id":"PMC_22811901","title":"Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling.","date":"2012","source":"Journal of signal transduction","url":"https://pubmed.ncbi.nlm.nih.gov/22811901","citation_count":63,"is_preprint":false},{"pmid":"21099353","id":"PMC_21099353","title":"Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21099353","citation_count":62,"is_preprint":false},{"pmid":"9885289","id":"PMC_9885289","title":"Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells.","date":"1999","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/9885289","citation_count":53,"is_preprint":false},{"pmid":"10805381","id":"PMC_10805381","title":"A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.","date":"2000","source":"The Histochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10805381","citation_count":50,"is_preprint":false},{"pmid":"25792458","id":"PMC_25792458","title":"Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25792458","citation_count":47,"is_preprint":false},{"pmid":"26646106","id":"PMC_26646106","title":"MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.","date":"2015","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26646106","citation_count":46,"is_preprint":false},{"pmid":"15496411","id":"PMC_15496411","title":"Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15496411","citation_count":45,"is_preprint":false},{"pmid":"31162891","id":"PMC_31162891","title":"AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting.","date":"2019","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31162891","citation_count":43,"is_preprint":false},{"pmid":"22710722","id":"PMC_22710722","title":"Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22710722","citation_count":43,"is_preprint":false},{"pmid":"22584896","id":"PMC_22584896","title":"The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells.","date":"2012","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22584896","citation_count":43,"is_preprint":false},{"pmid":"11820772","id":"PMC_11820772","title":"Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11820772","citation_count":42,"is_preprint":false},{"pmid":"25188285","id":"PMC_25188285","title":"PKA compartmentalization via AKAP220 and AKAP12 contributes to endothelial barrier regulation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25188285","citation_count":42,"is_preprint":false},{"pmid":"11493668","id":"PMC_11493668","title":"Functional interaction between the SSeCKS scaffolding protein and the cytoplasmic domain of beta1,4-galactosyltransferase.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11493668","citation_count":41,"is_preprint":false},{"pmid":"9350056","id":"PMC_9350056","title":"Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response.","date":"1997","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9350056","citation_count":39,"is_preprint":false},{"pmid":"17442483","id":"PMC_17442483","title":"AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity.","date":"2007","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/17442483","citation_count":38,"is_preprint":false},{"pmid":"16442664","id":"PMC_16442664","title":"G-Protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin).","date":"2006","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16442664","citation_count":37,"is_preprint":false},{"pmid":"16547152","id":"PMC_16547152","title":"SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.","date":"2006","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/16547152","citation_count":37,"is_preprint":false},{"pmid":"21334414","id":"PMC_21334414","title":"Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/21334414","citation_count":37,"is_preprint":false},{"pmid":"22052684","id":"PMC_22052684","title":"Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.","date":"2011","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22052684","citation_count":37,"is_preprint":false},{"pmid":"36122629","id":"PMC_36122629","title":"HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/36122629","citation_count":35,"is_preprint":false},{"pmid":"17626016","id":"PMC_17626016","title":"v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17626016","citation_count":34,"is_preprint":false},{"pmid":"22249313","id":"PMC_22249313","title":"SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus.","date":"2012","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22249313","citation_count":33,"is_preprint":false},{"pmid":"19055733","id":"PMC_19055733","title":"G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling.","date":"2008","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19055733","citation_count":33,"is_preprint":false},{"pmid":"32573313","id":"PMC_32573313","title":"AKAP12 Signaling Complex: Impacts of Compartmentalizing cAMP-Dependent Signaling Pathways in the Heart and Various Signaling Systems.","date":"2020","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/32573313","citation_count":32,"is_preprint":false},{"pmid":"22192928","id":"PMC_22192928","title":"AKAP12 regulates vascular integrity in zebrafish.","date":"2012","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22192928","citation_count":32,"is_preprint":false},{"pmid":"35576690","id":"PMC_35576690","title":"AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35576690","citation_count":31,"is_preprint":false},{"pmid":"29484387","id":"PMC_29484387","title":"Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29484387","citation_count":30,"is_preprint":false},{"pmid":"17686059","id":"PMC_17686059","title":"AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.","date":"2007","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/17686059","citation_count":30,"is_preprint":false},{"pmid":"24760034","id":"PMC_24760034","title":"AKAP12 mediates barrier functions of fibrotic scars during CNS repair.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24760034","citation_count":30,"is_preprint":false},{"pmid":"25229625","id":"PMC_25229625","title":"Prompt meningeal reconstruction mediated by oxygen-sensitive AKAP12 scaffolding protein after central nervous system injury.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25229625","citation_count":29,"is_preprint":false},{"pmid":"21903576","id":"PMC_21903576","title":"Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21903576","citation_count":28,"is_preprint":false},{"pmid":"12083796","id":"PMC_12083796","title":"Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12083796","citation_count":28,"is_preprint":false},{"pmid":"21918680","id":"PMC_21918680","title":"Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21918680","citation_count":28,"is_preprint":false},{"pmid":"16638134","id":"PMC_16638134","title":"SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.","date":"2006","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16638134","citation_count":27,"is_preprint":false},{"pmid":"31918285","id":"PMC_31918285","title":"MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31918285","citation_count":27,"is_preprint":false},{"pmid":"29391485","id":"PMC_29391485","title":"Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29391485","citation_count":27,"is_preprint":false},{"pmid":"20227403","id":"PMC_20227403","title":"Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.","date":"2010","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20227403","citation_count":27,"is_preprint":false},{"pmid":"11799143","id":"PMC_11799143","title":"Induction of Src-suppressed C kinase substrate (SSeCKS) in vascular endothelial cells by bacterial lipopolysaccharide.","date":"2002","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/11799143","citation_count":26,"is_preprint":false},{"pmid":"10469144","id":"PMC_10469144","title":"Developmental expression of the protein kinase C substrate/binding protein (clone 72/SSeCKS) in rat testis identification as a scaffolding protein containing an A-kinase-anchoring domain which is expressed during late-stage spermatogenesis.","date":"1999","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10469144","citation_count":26,"is_preprint":false},{"pmid":"33260683","id":"PMC_33260683","title":"AKAP12 Supports Blood-Brain Barrier Integrity against Ischemic Stroke.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33260683","citation_count":25,"is_preprint":false},{"pmid":"20939879","id":"PMC_20939879","title":"SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20939879","citation_count":25,"is_preprint":false},{"pmid":"11313943","id":"PMC_11313943","title":"Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313943","citation_count":25,"is_preprint":false},{"pmid":"29700280","id":"PMC_29700280","title":"Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution.","date":"2018","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29700280","citation_count":24,"is_preprint":false},{"pmid":"26891149","id":"PMC_26891149","title":"Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.","date":"2016","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/26891149","citation_count":24,"is_preprint":false},{"pmid":"20364105","id":"PMC_20364105","title":"Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.","date":"2010","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20364105","citation_count":23,"is_preprint":false},{"pmid":"18397319","id":"PMC_18397319","title":"AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Czeta.","date":"2008","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/18397319","citation_count":22,"is_preprint":false},{"pmid":"30385176","id":"PMC_30385176","title":"A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.","date":"2018","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30385176","citation_count":21,"is_preprint":false},{"pmid":"33251130","id":"PMC_33251130","title":"Long Non-Coding RNA MEG3 Modifies Cell-Cycle, Migration, Invasion, and Proliferation Through AKAP12 by Sponging miR-29c in Meningioma Cells.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33251130","citation_count":21,"is_preprint":false},{"pmid":"24029533","id":"PMC_24029533","title":"HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function.","date":"2013","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24029533","citation_count":21,"is_preprint":false},{"pmid":"19368818","id":"PMC_19368818","title":"Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line.","date":"2009","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19368818","citation_count":20,"is_preprint":false},{"pmid":"27683220","id":"PMC_27683220","title":"AKAP12 mediates PKA-induced phosphorylation of ATR to enhance nucleotide excision repair.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27683220","citation_count":20,"is_preprint":false},{"pmid":"30219663","id":"PMC_30219663","title":"LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation.","date":"2018","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30219663","citation_count":19,"is_preprint":false},{"pmid":"18950703","id":"PMC_18950703","title":"G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18950703","citation_count":19,"is_preprint":false},{"pmid":"15923193","id":"PMC_15923193","title":"Cross-species sequence analysis reveals multiple charged residue-rich domains that regulate nuclear/cytoplasmic partitioning and membrane localization of a kinase anchoring protein 12 (SSeCKS/Gravin).","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15923193","citation_count":19,"is_preprint":false},{"pmid":"37796990","id":"PMC_37796990","title":"Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood-brain barrier integrity.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37796990","citation_count":18,"is_preprint":false},{"pmid":"31894433","id":"PMC_31894433","title":"LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12.","date":"2020","source":"International journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31894433","citation_count":18,"is_preprint":false},{"pmid":"39448199","id":"PMC_39448199","title":"AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization.","date":"2024","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39448199","citation_count":17,"is_preprint":false},{"pmid":"33747281","id":"PMC_33747281","title":"MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression.","date":"2019","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/33747281","citation_count":17,"is_preprint":false},{"pmid":"30959452","id":"PMC_30959452","title":"Effect of the SSeCKS-TRAF6 interaction on gastrodin-mediated protection against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and neuronal death.","date":"2019","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/30959452","citation_count":17,"is_preprint":false},{"pmid":"32474964","id":"PMC_32474964","title":"Notch signaling regulates Akap12 expression and primary cilia length during renal tubule morphogenesis.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32474964","citation_count":16,"is_preprint":false},{"pmid":"24673440","id":"PMC_24673440","title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes astrocyte activation and the secretion of tumor necrosis factor-α via PKC/SSeCKS-dependent mechanisms.","date":"2014","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24673440","citation_count":16,"is_preprint":false},{"pmid":"21198787","id":"PMC_21198787","title":"Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis.","date":"2010","source":"Clinical and experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21198787","citation_count":16,"is_preprint":false},{"pmid":"34093646","id":"PMC_34093646","title":"Goat AKAP12: Indel Mutation Detection, Association Analysis With Litter Size and Alternative Splicing Variant Expression.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34093646","citation_count":15,"is_preprint":false},{"pmid":"21310466","id":"PMC_21310466","title":"Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.","date":"2011","source":"Urology","url":"https://pubmed.ncbi.nlm.nih.gov/21310466","citation_count":15,"is_preprint":false},{"pmid":"29501491","id":"PMC_29501491","title":"Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29501491","citation_count":15,"is_preprint":false},{"pmid":"35775596","id":"PMC_35775596","title":"Physiologic and pathophysiologic roles of AKAP12.","date":"2022","source":"Science progress","url":"https://pubmed.ncbi.nlm.nih.gov/35775596","citation_count":14,"is_preprint":false},{"pmid":"17551670","id":"PMC_17551670","title":"Lipopolysaccharide induces expression of SSeCKS in rat lung microvascular endothelial cell.","date":"2007","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17551670","citation_count":14,"is_preprint":false},{"pmid":"19757038","id":"PMC_19757038","title":"SSeCKS is a suppressor in Schwann cell differentiation and myelination.","date":"2009","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/19757038","citation_count":14,"is_preprint":false},{"pmid":"11429284","id":"PMC_11429284","title":"Gene trap insertion reveals two open reading frames in the mouse SSeCKS gene: the form predominantly detected in the nervous system is suppressed by the insertion while the other, specific of the testis, remains expressed.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11429284","citation_count":14,"is_preprint":false},{"pmid":"21831305","id":"PMC_21831305","title":"AKAP12 and AKAP5 form higher-order hetero-oligomers.","date":"2011","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21831305","citation_count":14,"is_preprint":false},{"pmid":"20568114","id":"PMC_20568114","title":"Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20568114","citation_count":14,"is_preprint":false},{"pmid":"34023860","id":"PMC_34023860","title":"Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34023860","citation_count":13,"is_preprint":false},{"pmid":"29050279","id":"PMC_29050279","title":"SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29050279","citation_count":12,"is_preprint":false},{"pmid":"21554706","id":"PMC_21554706","title":"AKAP5 and AKAP12 Form Homo-oligomers.","date":"2011","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21554706","citation_count":12,"is_preprint":false},{"pmid":"34483150","id":"PMC_34483150","title":"Overexpression of miR-146a promotes cell proliferation and migration in a model of diabetic foot ulcers by regulating the AKAP12 axis.","date":"2021","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/34483150","citation_count":12,"is_preprint":false},{"pmid":"18384053","id":"PMC_18384053","title":"Spatiotemporal expression of SSeCKS in injured rat sciatic nerve.","date":"2008","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/18384053","citation_count":11,"is_preprint":false},{"pmid":"38506047","id":"PMC_38506047","title":"AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.","date":"2024","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/38506047","citation_count":10,"is_preprint":false},{"pmid":"11814414","id":"PMC_11814414","title":"SSeCKS immunolabeling in rat primary sensory neurons.","date":"2002","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11814414","citation_count":10,"is_preprint":false},{"pmid":"15468953","id":"PMC_15468953","title":"The expression of src-suppressed C kinase substrate (SSeCKS) and uptake of exogenous particles in endothelial and reticular cells.","date":"2004","source":"Archives of histology and cytology","url":"https://pubmed.ncbi.nlm.nih.gov/15468953","citation_count":10,"is_preprint":false},{"pmid":"31632079","id":"PMC_31632079","title":"AKAP12 Endogenous Transcripts Suppress The Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Directly Targeting oncomiR-183-5p.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31632079","citation_count":9,"is_preprint":false},{"pmid":"25356636","id":"PMC_25356636","title":"Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25356636","citation_count":9,"is_preprint":false},{"pmid":"34359218","id":"PMC_34359218","title":"Exploration of Genetic Variants within the Goat A-Kinase Anchoring Protein 12 (AKAP12) Gene and Their Effects on Growth Traits.","date":"2021","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/34359218","citation_count":9,"is_preprint":false},{"pmid":"26428665","id":"PMC_26428665","title":"HSPA12B regulates SSeCKS-mediated astrocyte inflammatory activation in neuroinflammation.","date":"2015","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26428665","citation_count":8,"is_preprint":false},{"pmid":"30323895","id":"PMC_30323895","title":"SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30323895","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53788,"output_tokens":12408,"usd":0.173742,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23820,"output_tokens":10393,"usd":0.189463,"stage2_stop_reason":"end_turn"},"total_usd":0.363205,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"SSeCKS/AKAP12 associates with and controls elaboration of a cortical cytoskeletal matrix resistant to Triton X-100 extraction; ectopic SSeCKS expression in NIH3T3 cells caused cell flattening, loss of actin stress fibers and vinculin-associated adhesion plaques, and increased integrin-independent FAK tyrosine phosphorylation, establishing a direct role for SSeCKS in controlling actin-based cytoskeletal architecture.\",\n      \"method\": \"Tetracycline-regulated ectopic expression in NIH3T3 fibroblasts; immunofluorescence; cytochalasin/nocodazole inhibitor studies; biochemical fractionation\",\n      \"journal\": \"Cell motility and the cytoskeleton\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean inducible expression system with multiple orthogonal readouts (morphology, biochemistry, pharmacological perturbations), replicated in multiple papers\",\n      \"pmids\": [\"9744295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"SSeCKS re-expression in v-Src-transformed NIH3T3 cells suppressed oncogenic transformation parameters (soft agar growth, invasiveness, focus formation, low-serum growth) without inhibiting Src kinase activity or JNK activity, but induced ERK2 activity; SSeCKS restored vinculin-associated adhesion plaques, actin stress fibers, and filopodia, indicating tumor suppression via cytoskeletal and signaling control rather than direct Src kinase inhibition.\",\n      \"method\": \"Tetracycline-regulated SSeCKS expression in ts72v-src cell lines; soft agar assay; Matrigel invasion; in vivo/in vitro kinase assays; immunofluorescence\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays with inducible expression system, replicated across multiple subsequent studies\",\n      \"pmids\": [\"9187136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"SSeCKS induces G1 arrest by ERK2-dependent decrease in cyclin D1 expression and pRb phosphorylation; SSeCKS encodes two cyclin-binding (CY) motifs flanking PKC phosphorylation sites (Ser507/515) that bind cyclins D1 and E; K→S mutations in either CY motif ablate cyclin binding; PKC phosphorylation of SSeCKS at Ser507/515 releases cyclin D1 from cytoplasmic sequestration, allowing nuclear translocation; forced cyclin D1 re-expression fails to rescue SSeCKS-induced G1 arrest, demonstrating additional mechanisms.\",\n      \"method\": \"Tetracycline-regulated expression in NIH3T3; bacterially expressed SSeCKS-CY domain binding assays; site-directed mutagenesis; confocal microscopy; cell-permeable penetratin-linked peptides; pRb phosphorylation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding reconstitution with mutagenesis, live-cell imaging, and multiple orthogonal functional assays in one study\",\n      \"pmids\": [\"10982843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SSeCKS encodes four calmodulin (CaM) binding sites conforming to the 1-5-10 motif; CaM binding is antagonized by PKC pre-phosphorylation of SSeCKS; two major cyclin-binding (CY) sites overlap the major PKC phosphorylation site (Ser507/515), and cyclin D binding is attenuated by PKC pre-phosphorylation, demonstrating phosphorylation-dependent modulation of SSeCKS scaffolding activity.\",\n      \"method\": \"In vitro binding assays with bacterially expressed SSeCKS fragments; PKC phosphorylation prior to binding; mapping by deletion analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with phosphorylation-dependent functional mapping, single lab\",\n      \"pmids\": [\"11820772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SSeCKS/AKAP12 directly binds the cytoplasmic domain of beta1,4-galactosyltransferase I (GalT); identified by yeast two-hybrid screen and confirmed by reciprocal co-immunoprecipitation of both endogenous and transfected proteins; SSeCKS domains localized to Golgi (2.52) and filopodia (1.12) recapitulate GalT distribution; SSeCKS-GalT interaction restores normal adhesive phenotype disrupted by a dominant-negative GalT construct.\",\n      \"method\": \"Yeast two-hybrid screen; reciprocal co-immunoprecipitation; GFP-fusion localization; functional adhesion rescue assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with functional validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"11493668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Gravin/AKAP12 (AKAP250) dynamically associates with the beta2-adrenergic receptor (β2AR); the AKAP domain of gravin is essential for receptor binding (deletion abolishes binding); agonist stimulation induces gravin phosphorylation at two canonical PKA sites within its AKAP domain; PKA phosphorylation of these sites is required for scaffold-receptor association and for receptor resensitization; the AKAP-anchored PKA provides the catalytic activity responsible for phosphorylating the scaffold.\",\n      \"method\": \"Mutagenesis; metabolic labeling; biochemical co-immunoprecipitation; PKA inhibitor studies; receptor resensitization assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis combined with biochemical and functional assays; mechanism replicated in subsequent studies\",\n      \"pmids\": [\"14657015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SSeCKS in astrocytes decreases VEGF expression through AP-1 reduction and stimulates angiopoietin-1 expression; conditioned media from SSeCKS-overexpressing astrocytes blocks angiogenesis in vivo and in vitro, increases tight junction proteins in endothelial cells, and decreases sucrose permeability, establishing SSeCKS as a regulator of BBB differentiation.\",\n      \"method\": \"SSeCKS overexpression in astrocytes; conditioned media transfer to endothelial cells; in vivo and in vitro angiogenesis assays; [3H]sucrose permeability assay; immunofluorescence; in vivo BBB maturation immunostaining\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo assays, widely replicated across subsequent papers\",\n      \"pmids\": [\"12808449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"AKAP12 encodes three isoforms (alpha, beta, gamma) from three independent promoters with distinct tissue expression profiles; the alpha isoform contains an N-terminal myristoylation motif shown by deletion mapping and GFP chimeras to be necessary and sufficient for targeting AKAP12alpha to the endoplasmic reticulum, a novel AKAP12 subcellular compartment.\",\n      \"method\": \"Comparative genomics; reporter assays; GFP chimera subcellular localization; myristoylation site mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by live-cell imaging with mutagenesis validation, single lab\",\n      \"pmids\": [\"15496411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"AKAP12 contains five nuclear localization signals (NLS) in its central region (including a novel X2-NLS class) that confer nuclear targeting potential; this is suppressed by a negatively charged C-terminus mediating nuclear exclusion; three basic residue-rich regions in the N-terminal domain (similar to MARCKS) control AKAP12 localization to ganglioside-rich regions at the cell periphery, establishing a hierarchy of targeting domains.\",\n      \"method\": \"Cross-species sequence analysis; deletion mapping; GFP chimera live-cell imaging; subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GFP chimera localization with deletion mapping, single lab, no functional consequence directly demonstrated\",\n      \"pmids\": [\"15923193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SSeCKS re-expression suppresses podosome formation via inhibition of RhoA and Cdc42 activity (>5-fold reduction); activated RhoA and Cdc42 rescue podosome formation in SSeCKS-expressing v-Src cells; SSeCKS does not affect Tks5/Fish tyrosine phosphorylation or total cellular tyrosine phosphorylation, placing SSeCKS downstream of Src kinase activity but upstream of RhoA/Cdc42-mediated cytoskeletal remodeling.\",\n      \"method\": \"Tetracycline-regulated SSeCKS expression; RhoA/Cdc42 activity assays; constitutively active GTPase rescue; Matrigel invasion; immunofluorescence\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by constitutively active GTPase rescue combined with activity assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16547152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SSeCKS metastasis-suppressor activity correlates with suppression of VEGF expression in prostate cancer cells and tumor stroma; forced re-expression of VEGF165 or VEGF121 is sufficient to partially reverse SSeCKS metastasis suppression in both experimental and spontaneous lung metastasis models; SSeCKS also upregulates antiangiogenic genes (vasostatin, collagen 18a1) and downregulates proangiogenic genes (osteopontin, HIF-1alpha, angiopoietin).\",\n      \"method\": \"Tetracycline-regulated SSeCKS expression; spontaneous and experimental in vivo metastasis models; VEGF isoform forced re-expression rescue; gene expression analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo rescue experiments with defined molecular perturbations, replicated across multiple model systems\",\n      \"pmids\": [\"16740695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"AKAP12 downregulates HIF-1alpha protein by enhancing its interaction with pVHL (von Hippel-Lindau protein) and PHD2 (prolyl hydroxylase 2), leading to decreased VEGF and increased angiopoietin-1 in astrocytes; conditioned media from AKAP12-overexpressing astrocytes induces tight junction protein expression in human retinal microvascular endothelial cells, promoting blood-retinal barrier formation.\",\n      \"method\": \"AKAP12 overexpression in astrocytes; co-immunoprecipitation of HIF-1alpha with pVHL and PHD2; conditioned media transfer; tight junction protein western blot; in vivo immunostaining of human retinoblastoma samples\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of HIF-1alpha complex combined with functional conditioned media assays, single lab, multiple methods\",\n      \"pmids\": [\"17442832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"v-Src downregulates SSeCKS alpha promoter via recruitment of HDAC1 to a USF1-Sp1/Sp3 complex at E- and GC-box elements (-106 to -49); v-Src increases Sp1/Sp3 binding to the GC-box without altering protein abundance; Src-induced tyrosine phosphorylation of TFII-I increases its binding to the SSeCKS proximal promoter and is required for full transcriptional repression; trichostatin A (HDAC inhibitor) but not 5-azacytidine restores SSeCKS transcript levels.\",\n      \"method\": \"Promoter deletion analysis; chromatin immunoprecipitation; HDAC1 siRNA knockdown; electrophoretic mobility shift assay; TFII-I mass spectrometry identification; TFII-I tyrosine phosphorylation mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, EMSA, siRNA, and mutagenesis in one study, single lab\",\n      \"pmids\": [\"17626016\", \"20568114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AKAP12 in astrocytes reduces phosphorylation of PKCzeta in retinal endothelial cells; PKCzeta knockdown decreases VEGF and increases thrombospondin-1 (TSP-1); inhibition of Rho kinase (Y27632) downstream of PKCzeta also decreases VEGF and increases TSP-1, establishing an AKAP12→PKCzeta→Rho kinase→VEGF/TSP-1 pathway mediating barriergenesis.\",\n      \"method\": \"Conditioned media from AKAP12-overexpressing astrocytes; siRNA-mediated PKCzeta knockdown; Rho kinase inhibitor Y27632; western blot for VEGF and TSP-1\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and siRNA pathway dissection, single lab, indirect readout via conditioned media\",\n      \"pmids\": [\"18397319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Loss of SSeCKS/AKAP12 in knockout mice results in prostatic hyperplasia with focal dysplasia; SSeCKS-null prostate tissues exhibit significantly higher AKT(pS473) levels relative to wild-type, suggesting SSeCKS attenuates PI3K/AKT signaling in vivo.\",\n      \"method\": \"SSeCKS-null (knockout) mouse histology; western blot for pAKT(S473); E-cadherin and cytokeratin immunostaining\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse model with defined molecular readout, single lab\",\n      \"pmids\": [\"18593908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SSeCKS suppresses serum-induced Raf/MEK/ERK pathway activation, leading to decreased MMP-2 expression and inhibition of chemotaxis and Matrigel invasion; constitutively active MEK1, MEK2, ERK1, or PKCalpha restores invasiveness and chemotaxis; SSeCKS attenuation of ERK activation requires its PKC-binding domain (aa 553-900), suggesting direct PKC scaffolding; jasplakinolide (actin stabilizer) nullifies SSeCKS inhibition of MEK/ERK activation but not podosome inhibition.\",\n      \"method\": \"Tetracycline-regulated SSeCKS expression; constitutively active kinase rescue; SSeCKS domain deletion analysis; chemotaxis assay; Matrigel invasion; MEK/ERK phosphorylation western blot; actin cytoskeleton perturbation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis by constitutively active rescue combined with domain deletion mapping and pharmacological perturbations, multiple orthogonal methods\",\n      \"pmids\": [\"20018890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AKAP12-null MEF exhibit premature senescence marked by polyploidy and multinucleation; senescence is Rb-dependent; PKCα activation induces p16(Ink4a)/Rb through MEK-dependent downregulation of Id1; PKCδ downregulates Lats1/Warts kinase required for cytokinesis; Akap12 directly scaffolds and attenuates PKCα/δ, controlling Rb-mediated cell aging and cytokinesis.\",\n      \"method\": \"AKAP12-null (KO) mouse embryonic fibroblasts; PKC activity assays; p53/Rb pathway analysis; MEK inhibitor epistasis; senescence markers (SA-β-gal, p16, p21); polyploidy/multinucleation quantification\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO MEF with defined pathway epistasis, multiple orthogonal readouts, mechanistic pathway mapping\",\n      \"pmids\": [\"21099353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SSeCKS directly binds PKCα through two homologous motifs (EG(I/V)(T/S)XWXSFK(K/R)(M/L)VTP(K/R)K(K/R)X(K/R)XXXEXXXE(E/D); aa 592-620 and 741-769); SSeCKS binding to PKCα decreases kinase activity; SSeCKS scaffolding of PKC increases at confluence correlating with decreased PKCα activity; SSeCKS-null MEF show increased PKC activity and defective phorbol ester-induced actin cytoskeletal reorganization, rescued by full-length SSeCKS but not by PKC-binding domain-deleted SSeCKS.\",\n      \"method\": \"In vitro PKC binding assays with defined SSeCKS motifs; PKC kinase activity assays; SSeCKS-null MEF; domain deletion rescue; phorbol ester-induced cytoskeletal morphology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding reconstitution with motif mapping plus KO MEF rescue with deletion constructs, single lab\",\n      \"pmids\": [\"21903576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SSeCKS sequesters cyclin D1 in the cytoplasm of quiescent glomerular parietal epithelial cells (PECs); PKC phosphorylation of SSeCKS disrupts binding, resulting in nuclear translocation of cyclin D1; co-immunoprecipitation demonstrates cyclin D1-SSeCKS complex in PECs; SSeCKS-null mice show PEC hyperplasia with increased nuclear cyclin D1 and worse glomerular disease.\",\n      \"method\": \"Co-immunoprecipitation from capsulated glomeruli; confocal microscopy; SSeCKS-null mouse model; nephrotoxic nephritis model; cell culture contact inhibition experiments\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP from primary tissue confirmed by KO mouse model with disease phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"22249313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SSeCKS contains a Src-binding domain (aa 153-166) homologous to the caveolin-1 Src-binding domain; this domain mediates SSeCKS-Src interaction, SSeCKS-enhanced Src activity, and sequestration of Src to caveolin-rich lipid rafts; SSeCKS suppresses adhesion-induced Src activation (SrcpoY416) and FAK-Y925 phosphorylation while increasing FAK(pY397) and cell adhesion to fibronectin; lipid raft sequestration of Src disengages Src from FAK-associated adhesion complexes.\",\n      \"method\": \"In silico domain identification; co-immunoprecipitation; lipid raft fractionation; SSeCKS domain deletion mutants; FAK and Src phosphorylation western blots; cell adhesion assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain deletion combined with biochemical fractionation and phosphorylation assays, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22710722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"AKAP12 depletion in zebrafish (akap12 morphants) causes severe hemorrhage due to disorganized interendothelial cell-cell adhesions; AKAP12 knockdown in endothelial cells reduces expression of PAK2 (actin cytoskeletal regulator) and AF6 (connector of intercellular adhesion molecules to actin); PAK2 or AF6 knockdown phenocopies AKAP12 depletion; overexpression of PAK2 and AF6 rescues hemorrhage in akap12 morphants.\",\n      \"method\": \"Zebrafish morpholino knockdown; in vivo time-lapse imaging; siRNA knockdown in cultured endothelial cells; PAK2/AF6 western blot; morphant rescue by PAK2+AF6 overexpression\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo zebrafish model with molecular rescue, complemented by cell culture mechanistic studies\",\n      \"pmids\": [\"22192928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HDAC7 epigenetically silences AKAP12 in endothelial cells; siRNA depletion of HDAC7 causes H3 histone acetylation at the AKAP12 promoter, increasing AKAP12 mRNA and protein; elevated AKAP12 after HDAC7 depletion is responsible for inhibited migration and tube formation; AKAP12 mediates PKC-dependent phosphorylation of STAT3, which binds to the AKAP12 promoter and maintains elevated AKAP12 levels in a positive feedback loop.\",\n      \"method\": \"siRNA-mediated HDAC7 knockdown in HUVECs; proteomic analysis; ChIP for H3 acetylation; AKAP12 knockdown rescue; STAT3 ChIP at AKAP12 promoter; migration and tube formation assays\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with functional rescue experiments, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22584896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"AKAP12/gravin promoter contains two functional HIF-binding sites; site-directed mutagenesis identified the distal HIF-binding site as essential for hypoxia-induced gravin expression; gravin gain-of-function inhibits microvascular endothelial tube formation ('braking' system for angiogenesis); gravin functionally couples to control endothelial barrier function in response to PKA agonists.\",\n      \"method\": \"Cloned gravin promoter reporter assays; site-directed mutagenesis of HIF-binding sites; gravin gain/loss-of-function in endothelial cells; tube formation assays; transendothelial resistance measurements\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — promoter mutagenesis with functional gain/loss-of-function, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"24029533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKA compartmentalization by AKAP12 is required for cAMP-mediated endothelial barrier stabilization; siRNA depletion of AKAP12 significantly impairs endothelial barrier function; AKAP12 depletion redistributes PKA and Rac1 away from endothelial junctions and inactivates Rac1; TAT-Ahx-AKAPis peptide (competitive PKA-AKAP disruptor) destabilizes barrier and dampens forskolin/rolipram-mediated barrier enhancement.\",\n      \"method\": \"siRNA knockdown in microvascular endothelial cells; transendothelial electrical resistance; in vivo microvessel hydraulic conductivity; immunofluorescence for PKA/Rac1 localization; Rac1 activity assay; co-immunoprecipitation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown with in vivo validation, multiple readouts, competitive peptide inhibitor corroboration\",\n      \"pmids\": [\"25188285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SSeCKS controls chemotaxis and lamellipodia formation by scaffolding phosphoinositides through its three MARCKS polybasic domains (PBD); loss of SSeCKS shifts leading edge from lamellipodia to filopodia-like extensions, enriches PIP3, Akt, PKC-ζ, Cdc42-GTP, and active Src at the leading edge, and recruits Frabin (Cdc42-GEF) via PIP2/3 binding; full-length SSeCKS or ΔPBD-deleted SSeCKS fails to rescue, whereas ΔSrc variant rescues, placing PIP scaffolding above Src-binding in chemotaxis control.\",\n      \"method\": \"SSeCKS-null MEF; domain deletion mutants (ΔPBD, ΔSrc); Frabin knockdown; leading-edge PIP3/Rac1/Cdc42 imaging; co-immunoprecipitation (negative for SSeCKS-Frabin/Cdc42/Rac1 interaction); PI3K constitutively-active epistasis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO MEF with domain-deletion epistasis and knockdown rescue, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"25356636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"AKAP12 modulates meningeal EMT by regulating the TGF-β1-non-Smad-SNAI1 signaling pathway; AKAP12 expression in meningeal cells is regulated by integrated signals of TGF-β1, retinoic acid (RA), and oxygen tension; AKAP12-KO mice show impaired meningeal reconstruction after CNS injury.\",\n      \"method\": \"AKAP12-KO mice; CNS injury model; AKAP12 gain/loss-of-function in meningeal cells; TGF-β1/RA/oxygen tension manipulation; SNAI1 signaling analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with pathway analysis, single lab; pathway mechanistic detail (non-Smad SNAI1) not fully characterized in abstract\",\n      \"pmids\": [\"25229625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hypoxia selectively induces AKAP12 variant 2 (AKAP12v2) in metastatic melanoma; AKAP12v2 causes a shift in PKA-mediated phosphorylation events (identified by kinome-wide phosphoproteomics and MS) under hypoxia; this shift is due to changes in AKAP12 localization rather than structural differences between variants; the AKAP12-dependent phosphorylation shift alters tumor cell invasion and migration in vitro and metastasis in vivo.\",\n      \"method\": \"Kinome-wide phosphoproteomic and MS analysis; siRNA knockdown; gain-of-function expression of specific variant; in vitro invasion/migration assays; in vivo orthotopic melanoma model; immunofluorescence for localization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphoproteomics + MS + functional in vitro and in vivo validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"25792458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"AKAP12 scaffolds PKA to mediate phosphorylation of ATR at Ser435, a modification required for cAMP-enhanced nucleotide excision repair (NER); UV exposure promotes ATR-directed phosphorylation of AKAP12 at S732, driving nuclear translocation of the AKAP12-ATR-pS435 complex; this complex recruits XPA to UV-damaged DNA and enhances 5' strand incision; preventing AKAP12-PKA or AKAP12-ATR interaction abrogates ATR-pS435, delays XPA recruitment, impairs NER, and increases UV-induced mutagenesis.\",\n      \"method\": \"siRNA knockdown; AKAP12-PKA interaction-blocking mutants; AKAP12-ATR interaction mutants; NER assay (5' incision); XPA recruitment ChIP; phosphorylation site mutagenesis; UV mutagenesis assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — defined mechanistic complex with site-specific mutagenesis, functional NER assay, and recruitment assay, single lab\",\n      \"pmids\": [\"27683220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"AKAP12 localizes to lamellipodia in migrating endothelial cells and to tip cells at the angiogenic front in postnatal retina; AKAP12 co-localizes with PKA type II-α regulatory subunit, Arp2/3 complex components, and VASP; AKAP12 deletion results in defective vascular plexus extension; VEGF-stimulated PKA-dependent phosphorylation of VASP at Ser157 requires AKAP12, demonstrated by co-localization of phospho-Ser157 VASP with AKAP12 at the leading edge.\",\n      \"method\": \"siRNA knockdown in human endothelial cells; AKAP12-/- mice; immunoprecipitation and mass spectrometry; postnatal retinal vascular imaging; VASP phosphorylation western blot; immunofluorescence co-localization\",\n      \"journal\": \"Acta physiologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse model with MS-identified complex, functional vascular phenotype, and phosphorylation assay, multiple orthogonal methods\",\n      \"pmids\": [\"31162891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AKAP12 loss in endothelial cells causes upregulation/activation of the Rho kinase pathway and increased endothelial permeability with dysregulation of ZO-1/Claudin-5; Rho kinase inhibitor Y-27632 reverses increased permeability in AKAP12-deficient cells and tightens the BBB in Akap12 knockout mice after stroke, placing AKAP12 upstream of the Rho kinase pathway in BBB maintenance.\",\n      \"method\": \"siRNA knockdown in cultured cerebral endothelial cells; Akap12 KO mice; stroke (focal ischemia) model; Rho kinase activity assay; permeability assay; Rho kinase inhibitor rescue; ZO-1/Claudin-5 western blot\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse model corroborated by cell culture knockdown with pharmacological pathway rescue, multiple orthogonal methods\",\n      \"pmids\": [\"33260683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Notch signaling suppresses Akap12 expression during renal tubule morphogenesis; loss of Notch signaling increases Akap12 expression and results in abnormally long primary cilia; ectopic Akap12 expression phenocopies Notch loss (long cilia, defective lumen formation); Akap12 inhibits Notch-mediated transcription, suggesting a negative feedback loop.\",\n      \"method\": \"Dominant-negative mastermind-like (dnMaml) expression in renal epithelia; Akap12 ectopic expression; primary cilia length measurement; organoid (spheroid) lumen formation assay; Notch transcriptional reporter assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with phenotypic rescue and transcriptional reporter, single lab\",\n      \"pmids\": [\"32474964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HDAC6 directly interacts with AKAP12 and deacetylates it at K526/K531; deacetylation of AKAP12 at K531 by HDAC6 increases its ubiquitination level, facilitating proteasome-dependent degradation; deletion of AKAP12 in HDAC6-knockdown cells restores cell motility defects and reactivates PKC isoforms, placing AKAP12 downstream of HDAC6-mediated degradation in colon cancer metastasis control.\",\n      \"method\": \"Proteomic analysis; co-immunoprecipitation of HDAC6-AKAP12; site-specific acetylation mapping (K526/K531); ubiquitination assay; AKAP12 deletion rescue in HDAC6-KD cells; PKC activity assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — deacetylation substrate mapping with ubiquitination consequence and epistatic rescue, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"36122629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"AKAP12 overexpression in cardiac myocytes reduces total intracellular cAMP levels through PDE8 (not PDE4D); AKAP12-overexpressing mice show reduced cardiomyocyte contractility and impaired calcium handling in response to isoproterenol, reversed by selective PDE8 inhibitor (PF-04957325); AKAP12OX mice develop systolic dysfunction and left ventricular enlargement; patients with end-stage heart failure show upregulated AKAP12.\",\n      \"method\": \"Luciferase-based cAMP biosensor (GloSensor) in AC16 cardiomyocytes; adult primary cardiomyocyte contractility and calcium imaging; AKAP12 cardiac-specific overexpression mouse model; PDE8 inhibitor rescue; left ventricular function echocardiography\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — real-time cAMP measurement, KO rescue with specific PDE8 inhibitor, in vivo mouse model, and human patient validation; multiple orthogonal methods\",\n      \"pmids\": [\"38506047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SSeCKS/clone 72 contains a PKA RII-binding domain (aa 1495-1524) identified by deletion mutagenesis, confirming it is an AKAP; PKC-induced serine phosphorylation of SSeCKS causes rapid translocation to perinuclear sites, coincident with retraction of stellate processes in mesangial cells; ablation of SSeCKS by antisense retroviral vectors induces fibroblastic morphology, thick longitudinal stress fibers, and repositioning of vinculin-associated focal complexes.\",\n      \"method\": \"Deletion mutagenesis for RII binding; retroviral antisense vector knockdown; PKC activation with phorbol ester; bis-indolylmaleimide PKC inhibitor; immunofluorescence for SSeCKS, F-actin, vinculin\",\n      \"journal\": \"Journal of cell science / European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RII-binding domain mutagenesis plus antisense knockdown with defined cytoskeletal phenotypes, replicated across two independent studies\",\n      \"pmids\": [\"9885289\", \"10469144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SSeCKS tyrosine phosphorylation by mitogens (EGF, PDGF, serum) is FAK-dependent: FAK-deficient cells cannot phosphorylate SSeCKS upon EGF stimulation, rescued by re-expression of wild-type FAK but not FAK-Y397 mutant; purified FAK or Src fail to directly phosphorylate SSeCKS in vitro; phosphorylation is independent of Src/Fyn/Yes/Abl; unphosphorylated bacterially expressed SSeCKS co-sediments with F-actin; tyrosine phosphorylation modulates SSeCKS-actin interaction.\",\n      \"method\": \"FAK-/- MEF complementation; in vitro kinase assays with purified enzymes; [32P] metabolic labeling; F-actin co-sedimentation ultracentrifugation; immunofluorescence; coprecipitation with biotin-phalloidin\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution plus FAK-/- genetic rescue with mutagenesis and F-actin sedimentation, single lab\",\n      \"pmids\": [\"12083796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AKAP12/gravin is selectively required for resensitization and recycling of the beta2-adrenergic receptor: AKAP12 knockdown in A431 or HEK293 cells abolishes receptor resensitization, while AKAP5 knockdown does not; AKAP5 knockdown abolishes Erk1/2 activation downstream of beta2AR while AKAP12 knockdown does not, demonstrating non-redundant pathway segregation between the two AKAPs.\",\n      \"method\": \"siRNA knockdown of AKAP5 or AKAP12 in A431 and HEK293 cells; beta2AR resensitization assay; ERK1/2 phosphorylation assay; receptor recycling assay\",\n      \"journal\": \"Journal of molecular signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal siRNA knockdown in two cell lines with specific functional readouts, clean dissection of non-redundant roles\",\n      \"pmids\": [\"19055733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"AKAP12 forms higher-order homo-oligomers (behaving as dimers or tetramers ~840 kDa by steric-exclusion chromatography); both N-terminal (aa 1-840) and C-terminal (aa 840-1782) regions independently form dimers; AKAP12 and AKAP5 form hetero-oligomers demonstrated by affinity chromatography and steric-exclusion chromatography; beta-adrenergic agonist stimulation increases AKAP5-AKAP12 docking 4-fold; AKAP12 overexpression potentiates AKAP5-mediated ERK1/2 activation.\",\n      \"method\": \"SDS-PAGE/urea denaturation; steric-exclusion chromatography; affinity chromatography with immobilized AKAPs; co-immunoprecipitation; ERK1/2 phosphorylation assay with agonist stimulation\",\n      \"journal\": \"Journal of molecular signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — affinity chromatography and steric-exclusion chromatography with functional ERK readout, single lab\",\n      \"pmids\": [\"21554706\", \"21831305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Stromal SSeCKS/AKAP12 suppresses metastatic peritoneal colonization by attenuating secretion of Cxcl9/10 from peritoneal membrane fibroblasts; SSeCKS-null peritoneal fibroblasts exhibit senescence (SA-β-gal, p21, p16) and secrete elevated Cxcl10 in response to inflammatory mediators; Cxcr3 knockdown abrogates enhanced chemotaxis to KO peritoneal fluid; SSeCKS scaffolding-site mutants and kinase inhibitors show PKC, PKA, and PI3K/Akt pathways are responsible for Cxcl10 secretion control.\",\n      \"method\": \"SSeCKS-null mice; peritoneal fluid adoptive transfer; Cxcr3 knockdown; Cxcl10 neutralizing antibody; conditioned media from KO peritoneal membrane fibroblasts; SSeCKS scaffolding-site mutants; kinase inhibitors; senescence markers\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse adoptive transfer plus mechanistic domain mutant and inhibitor dissection, multiple orthogonal methods\",\n      \"pmids\": [\"29050279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SSeCKS/AKAP12 in lung fibroblasts suppresses metastatic melanoma colonization by attenuating Src/STAT3-dependent senescence-associated secretory phenotype; SSeCKS Src-scaffolding domain is required to attenuate IFNα-induced Stat3 activation in KO lung fibroblasts; KO lung endothelial cells exhibit increased E-Selectin levels facilitating melanoma adhesion.\",\n      \"method\": \"SSeCKS-null syngeneic mouse hosts; lung fibroblast conditioned media; co-injection of cancer cells with KO or WT lung fibroblasts; Stat3 activation assays; SSeCKS Src-scaffolding domain mutants; E-Selectin western blot\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with domain mutant epistasis, single lab, specific pathway readouts\",\n      \"pmids\": [\"30323895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HDAC3 directly binds within the intron-1 region of AKAP12 and this binding is indispensable for HDAC3-mediated inhibition of AKAP12 expression; HDAC3 inhibitors (TSA, RGFP966) restore AKAP12 expression; AKAP12 knockdown increases PI3K/AKT signaling activity, establishing PI3K/AKT as downstream of AKAP12 in colorectal cancer cells.\",\n      \"method\": \"ChIP for HDAC3 binding at AKAP12 intron-1; HDAC3 inhibitor treatment (TSA, RGFP966); AKAP12 siRNA knockdown; PI3K/AKT pathway western blot; colony formation and migration assays\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP binding evidence with pharmacological inhibitor validation, single lab\",\n      \"pmids\": [\"29484387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SSeCKS expression is decreased in differentiated Schwann cells; long-term SSeCKS knockdown changes Schwann cell morphology, accelerates myelin gene expression induced by cAMP, and enhances myelination in Schwann cell-DRG co-culture; SSeCKS suppression promotes Akt (Ser473) phosphorylation in cAMP-treated Schwann cells, identifying SSeCKS as a negative regulator of Schwann cell myelination.\",\n      \"method\": \"SSeCKS siRNA/antisense knockdown in Schwann cells; DRG co-culture myelination assay; myelin gene expression (RT-PCR); Akt phosphorylation western blot\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with functional myelination assay and signaling readout, single lab\",\n      \"pmids\": [\"19757038\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AKAP12/SSeCKS/Gravin is a large multivalent scaffold protein that spatiotemporally organizes PKA, PKC, calmodulin, cyclins D1/E, Src, phosphoinositides, and beta2-adrenergic receptors to control cell-cycle G1→S progression (by cytoplasmic sequestration of cyclin D1 released upon PKC-dependent phosphorylation), actin-based cytoskeletal architecture (by regulating RhoA/Cdc42/Rac1 GTPase balance and PIP2/3 scaffolding), metastatic signaling (by scaffolding PKC away from the Raf/MEK/ERK axis and sequestering Src to lipid rafts to disengage FAK), receptor resensitization (by PKA-dependent phosphorylation at its AKAP domain enabling β2AR re-association and recycling), blood-brain/blood-retinal barrier formation (by suppressing HIF-1α/VEGF and promoting angiopoietin-1 in astrocytes, and by compartmentalizing PKA-VASP signaling at endothelial leading edges), cardiac cAMP homeostasis (by coupling to PDE8 to limit PKA signaling downstream of β2AR), and DNA repair (by scaffolding PKA-mediated phosphorylation of ATR-S435 to recruit XPA to UV damage), while being subject to epigenetic repression (HDAC3/HDAC7-mediated transcriptional silencing; HDAC6-mediated deacetylation triggering ubiquitin-proteasomal degradation) and transcriptional downregulation in oncogenic contexts via Src-driven recruitment of HDAC1 to a USF1-Sp1/Sp3-TFII-I promoter complex.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"AKAP12 (SSeCKS/Gravin) is a large multivalent scaffold protein that spatiotemporally compartmentalizes kinases, cytoskeletal regulators, and signaling lipids to govern cytoskeletal architecture, cell-cycle progression, receptor recycling, and barriergenesis [#0, #2, #5, #6]. Its scaffolding logic is built from defined, phosphorylation-gated binding modules: it carries a PKA RII-binding domain establishing it as a bona fide AKAP [#33], cyclin-binding (CY) motifs that overlap PKC phosphorylation sites (Ser507/515) so that PKC phosphorylation releases cytoplasmically sequestered cyclin D1 for nuclear translocation [#2, #18], calmodulin-binding sites antagonized by PKC phosphorylation [#3], and direct PKCα-binding motifs through which AKAP12 binds and dampens PKC activity to restrain Rb-mediated senescence and cytoskeletal remodeling [#16, #17]. Through this architecture AKAP12 organizes actin-based cytoskeleton and adhesion, sequestering Src to caveolin-rich lipid rafts to disengage FAK and suppressing RhoA/Cdc42 to block podosome formation, and scaffolding phosphoinositides via MARCKS-like polybasic domains to direct lamellipodial chemotaxis [#0, #9, #19, #24]. It functions as a tumor and metastasis suppressor by attenuating Raf/MEK/ERK signaling away from a sequestered PKC pool, reducing MMP-2, VEGF, and invasion [#1, #10, #15]. In endothelial and astrocytic compartments AKAP12 drives blood-brain/blood-retinal barrier formation by suppressing HIF-1α/VEGF and inducing angiopoietin-1, and by compartmentalizing PKA-VASP/Rac1 signaling at endothelial junctions and leading edges while restraining the Rho kinase pathway [#6, #11, #28, #29]. As an AKAP it phosphorylation-dependently re-associates with the β2-adrenergic receptor to enable resensitization and recycling [#5, #35], and in cardiomyocytes couples to PDE8 to limit intracellular cAMP and contractility [#32]; it also scaffolds PKA-mediated phosphorylation of ATR-S435 to recruit XPA during nucleotide excision repair [#27]. AKAP12 expression and stability are tightly controlled, undergoing epigenetic silencing by HDAC3/HDAC7 and Src-driven HDAC1 recruitment, and HDAC6-mediated deacetylation that triggers ubiquitin-proteasomal degradation [#12, #21, #31, #39].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that re-expression of SSeCKS reverses oncogenic transformation answered whether this protein is a functional tumor suppressor and whether it acts on Src directly.\",\n      \"evidence\": \"Tetracycline-regulated SSeCKS re-expression in v-Src-transformed NIH3T3 with soft agar, invasion, and kinase assays\",\n      \"pmids\": [\"9187136\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the molecular target through which SSeCKS suppresses transformation downstream of intact Src activity\", \"Did not define direct binding partners\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that ectopic SSeCKS reorganizes the cortical cytoskeleton established its primary role as a controller of actin-based architecture and adhesion.\",\n      \"evidence\": \"Inducible expression in NIH3T3 with immunofluorescence, fractionation, and cytoskeletal inhibitor studies\",\n      \"pmids\": [\"9744295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the signaling molecules scaffolded to drive cytoskeletal changes\", \"Mechanism linking FAK phosphorylation to morphology unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of the PKA RII-binding domain and PKC-triggered translocation defined SSeCKS as an AKAP whose localization is phosphorylation-regulated.\",\n      \"evidence\": \"Deletion mutagenesis for RII binding and antisense knockdown with phorbol ester in mesangial cells\",\n      \"pmids\": [\"9885289\", \"10469144\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not link RII anchoring to a specific downstream PKA substrate\", \"Functional consequence of perinuclear translocation undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping cyclin-binding motifs overlapping PKC phosphorylation sites answered how SSeCKS couples kinase signaling to cell-cycle control via cyclin D1 sequestration.\",\n      \"evidence\": \"In vitro CY-domain binding, site-directed mutagenesis, confocal imaging, and pRb assays in NIH3T3\",\n      \"pmids\": [\"10982843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Forced cyclin D1 re-expression did not rescue G1 arrest, indicating uncharacterized additional mechanisms\", \"ERK2-dependent cyclin D1 downregulation mechanism not fully resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating calmodulin binding and phosphorylation-attenuated cyclin binding established that PKC phosphorylation is a master switch modulating multiple SSeCKS scaffolding outputs.\",\n      \"evidence\": \"In vitro binding of bacterial SSeCKS fragments with PKC pre-phosphorylation and deletion mapping\",\n      \"pmids\": [\"11820772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequence of CaM binding not directly demonstrated\", \"Single-lab in vitro reconstitution\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing FAK-dependent, indirect tyrosine phosphorylation of SSeCKS clarified how mitogenic signaling modulates its actin association.\",\n      \"evidence\": \"FAK-/- MEF complementation, in vitro kinase assays, and F-actin co-sedimentation\",\n      \"pmids\": [\"12083796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The actual kinase phosphorylating SSeCKS downstream of FAK was not identified\", \"Tyrosine sites on SSeCKS not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining gravin-β2AR association through its AKAP domain and PKA phosphorylation answered how an AKAP scaffold enables receptor resensitization.\",\n      \"evidence\": \"Mutagenesis, metabolic labeling, Co-IP, and resensitization assays\",\n      \"pmids\": [\"14657015\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether other receptors use the same docking mechanism\", \"Dynamics of association/dissociation in cells incompletely resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating SSeCKS-driven VEGF suppression and angiopoietin-1 induction in astrocytes established its role in blood-brain barrier differentiation.\",\n      \"evidence\": \"Astrocyte overexpression, conditioned media transfer, angiogenesis and sucrose permeability assays in vivo and in vitro\",\n      \"pmids\": [\"12808449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of VEGF suppression not yet defined\", \"Endothelial signaling target of secreted factors unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Characterization of three promoter-driven isoforms with distinct targeting (including myristoylation-driven ER localization) revealed isoform-specific subcellular compartmentalization.\",\n      \"evidence\": \"Comparative genomics, reporter assays, GFP chimeras, and myristoylation mutagenesis\",\n      \"pmids\": [\"15496411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional distinction between isoforms not established\", \"ER-localized AKAP12α role undefined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping NLS, nuclear-exclusion, and peripheral targeting domains established a hierarchy of localization signals governing AKAP12 distribution.\",\n      \"evidence\": \"Cross-species sequence analysis, deletion mapping, GFP chimera imaging, and fractionation\",\n      \"pmids\": [\"15923193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional consequence of differential localization directly demonstrated\", \"Conditions triggering nuclear import not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placing SSeCKS downstream of Src but upstream of RhoA/Cdc42 in podosome suppression connected its tumor-suppressor activity to GTPase-mediated cytoskeletal remodeling.\",\n      \"evidence\": \"Inducible expression, GTPase activity assays, constitutively active GTPase rescue, and invasion assays\",\n      \"pmids\": [\"16547152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which SSeCKS lowers RhoA/Cdc42 activity not defined\", \"Direct GTPase regulators involved unidentified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing VEGF re-expression partially reverses metastasis suppression established VEGF/angiogenic gene control as a key effector of SSeCKS metastasis suppression in vivo.\",\n      \"evidence\": \"Inducible expression, spontaneous/experimental metastasis models, and VEGF isoform rescue\",\n      \"pmids\": [\"16740695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Partial reversal indicates VEGF-independent mechanisms remain\", \"Transcriptional mechanism of VEGF/HIF-1α regulation not resolved here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating AKAP12 enhances pVHL/PHD2-dependent HIF-1α degradation answered how it suppresses VEGF and promotes blood-retinal barrier formation.\",\n      \"evidence\": \"Astrocyte overexpression, Co-IP of HIF-1α with pVHL/PHD2, and conditioned media tight-junction assays\",\n      \"pmids\": [\"17442832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AKAP12 directly contacts the HIF degradation machinery is not established\", \"Mechanism enhancing the pVHL/PHD2 interaction unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining v-Src-driven HDAC1/USF1/Sp1-Sp3/TFII-I promoter repression revealed the transcriptional mechanism by which oncogenic signaling silences SSeCKS.\",\n      \"evidence\": \"Promoter deletion, ChIP, HDAC1 siRNA, EMSA, and TFII-I phosphorylation mutants\",\n      \"pmids\": [\"17626016\", \"20568114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how Src activates this promoter complex mechanistically\", \"Generality across cell types untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Tracing an AKAP12→PKCζ→Rho kinase→VEGF/TSP-1 axis and the prostatic AKT phenotype connected AKAP12 loss to elevated angiogenic and PI3K/AKT signaling in tissue.\",\n      \"evidence\": \"Conditioned media with PKCζ siRNA and Rho kinase inhibitor; SSeCKS-null prostate histology with pAKT blots\",\n      \"pmids\": [\"18397319\", \"18593908\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Indirect conditioned-media readout for the PKCζ pathway\", \"Mechanism linking AKAP12 to AKT attenuation in prostate not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Reciprocal siRNA dissection of AKAP12 versus AKAP5 established non-redundant segregation of β2AR resensitization (AKAP12) from ERK activation (AKAP5).\",\n      \"evidence\": \"Reciprocal siRNA knockdown in A431 and HEK293 with resensitization, recycling, and ERK assays\",\n      \"pmids\": [\"19055733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for pathway segregation not determined\", \"Whether the two AKAPs physically interact addressed only later\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing SSeCKS attenuates Raf/MEK/ERK via its PKC-binding domain to reduce MMP-2 and invasion established the kinase-scaffolding basis of its anti-invasive activity.\",\n      \"evidence\": \"Inducible expression, constitutively active kinase rescue, domain deletion, and actin perturbation\",\n      \"pmids\": [\"20018890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct demonstration of PKC-Raf disengagement on the scaffold not shown\", \"Link between actin and MEK/ERK attenuation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining premature senescence in AKAP12-null MEF through PKCα/δ scaffolding revealed AKAP12 control over Rb-mediated aging and cytokinesis.\",\n      \"evidence\": \"KO MEF with PKC activity assays, MEK inhibitor epistasis, and senescence/polyploidy quantification\",\n      \"pmids\": [\"21099353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKCα/δ binding shown definitively in a later study\", \"Connection between Lats1 downregulation and PKCδ not fully mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapping two PKCα-binding motifs and showing binding inhibits PKC activity provided the biochemical basis for AKAP12 as a PKC-sequestering scaffold.\",\n      \"evidence\": \"In vitro motif-defined binding and kinase assays plus KO MEF rescue with deletion constructs\",\n      \"pmids\": [\"21903576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all PKC isoforms share the same binding mode unresolved\", \"Single-lab in vitro reconstitution\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating AKAP12 homo-oligomerization and hetero-oligomerization with AKAP5 indicated higher-order scaffold assembly that potentiates ERK signaling.\",\n      \"evidence\": \"Steric-exclusion and affinity chromatography, Co-IP, and ERK assays with agonist\",\n      \"pmids\": [\"21554706\", \"21831305\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of oligomerization not established in vivo\", \"Stoichiometry and structural basis undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying the caveolin-1-like Src-binding domain that sequesters Src to lipid rafts explained how SSeCKS disengages Src from FAK adhesion complexes.\",\n      \"evidence\": \"Domain identification, Co-IP, lipid raft fractionation, deletion mutants, and FAK/Src phosphorylation assays\",\n      \"pmids\": [\"22710722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural verification of raft targeting absent\", \"How Src sequestration alters adhesion dynamics over time unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Confirming cytoplasmic cyclin D1 sequestration in quiescent epithelial cells with a KO disease phenotype validated the cyclin-control model in vivo.\",\n      \"evidence\": \"Co-IP from primary glomeruli, confocal imaging, and SSeCKS-null nephritis model\",\n      \"pmids\": [\"22249313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKC kinase identity driving release in vivo not specified\", \"Generalizability beyond glomerular epithelium untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking AKAP12 to PAK2/AF6-dependent endothelial junction integrity in zebrafish established its requirement for vascular barrier maintenance in vivo.\",\n      \"evidence\": \"Morpholino knockdown with in vivo imaging, cell culture siRNA, and PAK2+AF6 rescue\",\n      \"pmids\": [\"22192928\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which AKAP12 controls PAK2/AF6 expression not defined\", \"Direct binding to junctional components untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating HDAC7-mediated silencing and a PKC-STAT3 positive feedback loop revealed epigenetic control of AKAP12 in endothelial cells.\",\n      \"evidence\": \"HDAC7 siRNA, H3 acetylation ChIP, STAT3 ChIP at the promoter, and migration/tube assays\",\n      \"pmids\": [\"22584896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct STAT3-AKAP12 promoter regulatory architecture incompletely mapped\", \"Whether feedback operates in other cell types untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying functional HIF-binding sites in the gravin promoter and a barrier-stabilizing role connected hypoxia sensing to AKAP12-mediated angiogenic braking.\",\n      \"evidence\": \"Promoter reporter assays, HIF-site mutagenesis, gain/loss-of-function, and transendothelial resistance\",\n      \"pmids\": [\"24029533\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between HIF-driven induction and AKAP12-driven HIF-1α suppression unresolved\", \"Single-lab promoter dissection\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing AKAP12-anchored PKA and Rac1 are required for cAMP-mediated endothelial barrier stabilization defined a junctional compartmentalization mechanism.\",\n      \"evidence\": \"siRNA knockdown, transendothelial resistance, in vivo hydraulic conductivity, Rac1 assays, and AKAP-disruptor peptide\",\n      \"pmids\": [\"25188285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKA substrate at junctions not identified here\", \"Link between PKA anchoring and Rac1 activation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing phosphoinositide scaffolding via MARCKS polybasic domains, ranked above Src binding, defined how SSeCKS directs lamellipodial chemotaxis.\",\n      \"evidence\": \"KO MEF, ΔPBD/ΔSrc deletion epistasis, Frabin knockdown, and leading-edge PIP3/GTPase imaging\",\n      \"pmids\": [\"25356636\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct lipid-binding affinities not quantified\", \"How PBD scaffolding spatially restricts Cdc42-GEF activity unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linking AKAP12 to TGF-β1-non-Smad-SNAI1 signaling in meningeal EMT established a role in CNS injury reconstruction.\",\n      \"evidence\": \"AKAP12-KO mice with CNS injury model and gain/loss-of-function under TGF-β1/RA/oxygen manipulation\",\n      \"pmids\": [\"25229625\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Non-Smad SNAI1 mechanistic detail not fully characterized\", \"Direct AKAP12 scaffolding role in the pathway undefined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing hypoxia induces AKAP12 variant 2 to shift PKA-mediated phosphorylation events connected localization-driven scaffold variation to metastatic behavior.\",\n      \"evidence\": \"Kinome-wide phosphoproteomics/MS, siRNA, variant gain-of-function, and orthotopic melanoma model\",\n      \"pmids\": [\"25792458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PKA substrates driving the invasive shift not all defined\", \"Mechanism of variant-specific localization unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defining the AKAP12-PKA-ATR-S435 complex that recruits XPA established a direct role for AKAP12 scaffolding in nucleotide excision repair.\",\n      \"evidence\": \"siRNA, interaction-blocking mutants, NER incision assay, XPA recruitment, and UV mutagenesis assay\",\n      \"pmids\": [\"27683220\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural organization of the nuclear complex undefined\", \"How UV signals to ATR-directed AKAP12 phosphorylation incompletely mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating stromal SSeCKS suppresses peritoneal colonization via Cxcl9/10 control implicated scaffold-regulated stromal secretion in metastasis suppression.\",\n      \"evidence\": \"SSeCKS-null mice, peritoneal fluid adoptive transfer, Cxcr3 knockdown, scaffolding-site mutants, and kinase inhibitors\",\n      \"pmids\": [\"29050279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PKC/PKA/PI3K pathways to chemokine control not separated\", \"Link between fibroblast senescence and chemokine output mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showing fibroblast SSeCKS attenuates Src/STAT3-dependent SASP extended its stromal metastasis-suppressor role to lung colonization.\",\n      \"evidence\": \"SSeCKS-null syngeneic hosts, co-injection assays, STAT3 activation, Src-scaffolding domain mutants, and E-Selectin blots\",\n      \"pmids\": [\"30323895\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Src-STAT3 scaffolding on AKAP12 not biochemically resolved\", \"Endothelial E-Selectin regulation mechanism undefined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying HDAC3 binding at AKAP12 intron-1 as repressive, with PI3K/AKT as a downstream effector, added a second epigenetic silencing mechanism in colorectal cancer.\",\n      \"evidence\": \"HDAC3 ChIP, inhibitor treatment, AKAP12 siRNA, and PI3K/AKT blots\",\n      \"pmids\": [\"29484387\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How HDAC3 represses from an intronic site mechanistically unresolved\", \"Direct vs indirect AKAP12 control of PI3K/AKT undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Localizing AKAP12 with PKA-RIIα, Arp2/3, and VASP at endothelial tip-cell leading edges defined a PKA-VASP compartment driving angiogenic sprouting.\",\n      \"evidence\": \"siRNA, AKAP12-/- mice, IP-MS, postnatal retinal imaging, and VASP-Ser157 phosphorylation assays\",\n      \"pmids\": [\"31162891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct AKAP12-VASP contact not established\", \"Spatial coupling of Arp2/3 to the scaffold mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placing AKAP12 upstream of Rho kinase in BBB maintenance, with pharmacological rescue after stroke, connected AKAP12 loss to junctional permeability through ROCK activation.\",\n      \"evidence\": \"siRNA in cerebral endothelial cells, Akap12 KO stroke model, Rho kinase assays, and Y-27632 rescue\",\n      \"pmids\": [\"33260683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which AKAP12 restrains Rho kinase not defined\", \"Link to ZO-1/Claudin-5 regulation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing Notch suppresses Akap12 and that ectopic Akap12 causes ciliary/lumen defects revealed a Notch-AKAP12 negative feedback loop in renal morphogenesis.\",\n      \"evidence\": \"dnMaml expression, Akap12 ectopic expression, cilia length and lumen assays, and Notch reporter\",\n      \"pmids\": [\"32474964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Akap12 inhibits Notch transcription undefined\", \"Direct molecular link to ciliary length control unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying HDAC6 deacetylation of AKAP12 at K531 as a trigger for ubiquitin-proteasomal degradation revealed post-translational control coupling AKAP12 stability to PKC reactivation in metastasis.\",\n      \"evidence\": \"Proteomics, HDAC6-AKAP12 Co-IP, acetylation site mapping, ubiquitination assay, and AKAP12 deletion rescue\",\n      \"pmids\": [\"36122629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating AKAP12 ubiquitination not identified\", \"How acetylation status shifts under physiological cues unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating AKAP12 couples to PDE8 to limit cardiac cAMP, with a heart-failure phenotype and human validation, defined a cardiac cAMP-homeostasis role.\",\n      \"evidence\": \"GloSensor cAMP biosensor, primary cardiomyocyte contractility/calcium imaging, cardiac-specific overexpression mice, PDE8 inhibitor rescue, and human failing-heart samples\",\n      \"pmids\": [\"38506047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct AKAP12-PDE8 binding architecture not detailed\", \"Whether endogenous AKAP12 loss has reciprocal cardiac effects untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many AKAP12 scaffolding modules are integrated structurally into a single multivalent platform, and how isoform/localization choice selects among its competing signaling outputs, remains unresolved.\",\n      \"evidence\": \"No structural or integrated-systems study in the available corpus resolves module coordination\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of full-length AKAP12 or its assembled complexes\", \"Rules selecting between PKA, PKC, cyclin, Src, and PIP scaffolding outputs in a given context unknown\", \"In vivo stoichiometry of competing partner binding undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 5, 17, 27, 33]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [17, 16, 19, 32]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 34, 24]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [2, 18, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 33, 24]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 19, 24]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 27]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 15, 35, 32]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [2, 16, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 10, 31, 37]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [27]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [20, 23, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 25, 28, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PRKACA\", \"PRKCA\", \"SRC\", \"CCND1\", \"ATR\", \"AKAP5\", \"ADRB2\", \"B4GALT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}